<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="hwp">genetics</journal-id>
<journal-id journal-id-type="pmc">genetics</journal-id>
<journal-id journal-id-type="publisher-id">genetics</journal-id>
<journal-title>Genetics</journal-title>
<abbrev-journal-title abbrev-type="full">Genetics</abbrev-journal-title>
<issn pub-type="ppub">0016-6731</issn>
<issn pub-type="epub">1943-2631</issn>
<publisher><publisher-name>Genetics Society of America</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">GEN_198820</article-id>
<article-id pub-id-type="doi">10.1534/genetics.116.198820</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Investigation</subject></subj-group>
</article-categories>
<title-group>
<article-title>The NCA-1 and NCA-2 Ion Channels Function Downstream of G<sub>q</sub> and Rho To Regulate Locomotion in <italic>Caenorhabditis elegans</italic></article-title>
<?RFL  I. Topalidou <italic>et al.</italic>?>
<?RFR  Gq Signaling Activates NCA Channels Through Rho?>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Topalidou</surname><given-names>Irini</given-names></name><xref ref-type="aff" rid="aff1">&#x002A;</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Pin-An</given-names></name><xref ref-type="aff" rid="aff2"><sup>&#x2020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cooper</surname><given-names>Kirsten</given-names></name><xref ref-type="aff" rid="aff1">&#x002A;</xref><xref ref-type="fn" rid="afn1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Watanabe</surname><given-names>Shigeki</given-names></name><xref ref-type="aff" rid="aff2"><sup>&#x2020;</sup></xref><xref ref-type="fn" rid="afn2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jorgensen</surname><given-names>Erik M.</given-names></name><xref ref-type="aff" rid="aff2"><sup>&#x2020;</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Ailion</surname><given-names>Michael</given-names></name><uri content-type="orcid">http://orcid.org/0000-0002-8070-1362</uri><xref ref-type="aff" rid="aff1">&#x002A;</xref><xref ref-type="corresp" rid="cor1"><sup>3</sup></xref></contrib>
<aff id="aff1"><label>&#x002A;</label>Department of Biochemistry, University of Washington, Seattle, Washington 98195</aff>
<aff id="aff2"><label>&#x2020;</label>Howard Hughes Medical Institute, Department of Biology, University of Utah, Salt Lake City, Utah 84112</aff>
</contrib-group>
<author-notes>
<fn id="afn1"><label>1</label><p>Present Address: Fred Hutchinson Cancer Research Center, Seattle, WA 98109.</p></fn>
<fn id="afn2"><label>2</label><p>Present Address: Department of Cell Biology, Johns Hopkins University, Baltimore, MD 21205.</p></fn>
<corresp id="cor1"><label>3</label>Corresponding author: Department of Biochemistry, University of Washington, Box 357350, 1705 NE Pacific St., Seattle, WA 98195. E-mail: <email>mailion@uw.edu</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>05</month><year>2017</year></pub-date>
<pub-date pub-type="epub"><day>20</day><month>3</month><year>2017</year></pub-date>
<volume>206</volume>
<issue>1</issue>
<fpage>0</fpage>
<lpage>0</lpage>
<history>
<date date-type="received"><day>02</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>15</day><month>03</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2017 by the Genetics Society of America</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:title="pdf" xlink:href="GEN_198820.pdf"/>
<abstract>
<p>The heterotrimeric G protein G<sub>q</sub> positively regulates neuronal activity and synaptic transmission. Previously, the Rho guanine nucleotide exchange factor Trio was identified<!-- Q1 --> as a direct effector of G<sub>q</sub> that acts in parallel to the canonical G<sub>q</sub> effector phospholipase C<!-- DBComment1 -->. Here, we examine how Trio and Rho act to stimulate neuronal activity downstream of G<sub>q</sub> in the nematode <italic>Caenorhabditis elegans</italic>. Through two forward genetic screens, we identify the cation channels NCA-1 and NCA-2, orthologs of mammalian NALCN, as downstream targets of the G<sub>q</sub>/Rho pathway. By performing genetic epistasis analysis using dominant activating mutations and recessive loss-of-function mutations in the members of this pathway, we show that NCA-1 and NCA-2 act downstream of G<sub>q</sub> in a linear pathway. Through cell-specific rescue experiments, we show that function of these channels in head acetylcholine neurons is sufficient for normal locomotion in <italic>C. elegans</italic>. Our results suggest that NCA-1 and NCA-2 are physiologically relevant targets of neuronal G<sub>q</sub>-Rho signaling in <italic>C. elegans</italic>.</p>
</abstract>
<kwd-group>
<kwd>G<sub>q</sub> signaling</kwd><kwd>Rho small GTPase</kwd><kwd>NCA/NALCN ion channels</kwd><kwd><italic>C. elegans</italic></kwd><kwd>G protein</kwd>
</kwd-group>
<counts>
<fig-count count="10"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="81"/>
<page-count count="0"/></counts>
<!--*Department of Biochemistry, University of Washington, Seattle, Washington 98195 and <sup>&#x2020;</sup>Howard Hughes Medical Institute, Department of Biology, University of Utah, Salt Lake City, Utah 84112-->
</article-meta>
</front>
<body>
<p>HETEROTRIMERIC G proteins play central roles in altering neuronal<!-- Q2 --><!-- Q3 --><!-- Q4 --><!-- Q5 --> activity<!-- Q6 --> and synaptic transmission in response to experience or changes in the environment<!-- DBComment2 --> <!-- DBComment3 --> <!-- DBComment4 --> <!-- DBComment5 --> <!-- DBComment6 -->. G<sub>q</sub> is one of the four types of heterotrimeric G protein &#x03B1; subunits in animals (<xref ref-type="bibr" rid="bib78">Wilkie <italic>et al.</italic> 1992</xref>). G<sub>q</sub> is widely expressed in the mammalian brain (<xref ref-type="bibr" rid="bib77">Wilkie <italic>et al.</italic> 1991</xref>) where it acts to stimulate neuronal activity (<xref ref-type="bibr" rid="bib37">Krause <italic>et al.</italic> 2002</xref>; <xref ref-type="bibr" rid="bib24">Gamper <italic>et al.</italic> 2004</xref>; <xref ref-type="bibr" rid="bib16">Coulon <italic>et al.</italic> 2010</xref>). Unlike mammals, which have four members of the G<sub>q</sub> family, <italic>Caenorhabditis elegans</italic> has only a single G<sub>q</sub>&#x03B1; gene <italic>egl-30</italic> (<xref ref-type="bibr" rid="bib11">Brundage <italic>et al.</italic> 1996</xref>). Loss-of-function and gain-of-function mutants in <italic>egl-30</italic> are viable but have strong neuronal phenotypes, affecting locomotion, egg laying, and sensory behaviors (<xref ref-type="bibr" rid="bib11">Brundage <italic>et al.</italic> 1996</xref>; <xref ref-type="bibr" rid="bib38">Lackner <italic>et al.</italic> 1999</xref>; <xref ref-type="bibr" rid="bib7">Bastiani <italic>et al.</italic> 2003</xref>; <xref ref-type="bibr" rid="bib52">Matsuki <italic>et al.</italic> 2006</xref>; <xref ref-type="bibr" rid="bib1">Adachi <italic>et al.</italic> 2010</xref>; <xref ref-type="bibr" rid="bib19">Esposito <italic>et al.</italic> 2010</xref>). We aim to identify the downstream pathways by which G<sub>q</sub> signaling alters neuronal activity.</p>
<p>In the canonical G<sub>q</sub> pathway, G<sub>q</sub> activates phospholipase C&#x03B2; (PLC) to cleave the lipid phosphatidylinositol 4,5-bisphosphate (PIP2) into the second-messengers diacylglycerol (DAG) and inositol trisphosphate. This pathway operates in both worms and mammals, but in both systems, a number of PLC-independent effects of G<sub>q</sub> have been described (<xref ref-type="bibr" rid="bib38">Lackner <italic>et al.</italic> 1999</xref>; <xref ref-type="bibr" rid="bib56">Miller <italic>et al.</italic> 1999</xref>; <xref ref-type="bibr" rid="bib7">Bastiani <italic>et al.</italic> 2003</xref>; <xref ref-type="bibr" rid="bib74">Vogt <italic>et al.</italic> 2003</xref>; <xref ref-type="bibr" rid="bib62">S&#x00E1;nchez-Fern&#x00E1;ndez <italic>et al.</italic> 2014</xref>). Using a genetic screen for suppressors of activated G<sub>q</sub>, we identified the Rho guanine nucleotide exchange factor (GEF) Trio as a direct effector of G<sub>q</sub> in a second major conserved G<sub>q</sub> signal transduction pathway independent of the PLC pathway (<xref ref-type="bibr" rid="bib79">Williams <italic>et al.</italic> 2007</xref>). Biochemical and structural studies demonstrated that G<sub>q</sub> directly binds and activates RhoGEF proteins in both worms and mammals (<xref ref-type="bibr" rid="bib50">Lutz <italic>et al.</italic> 2005</xref>, <xref ref-type="bibr" rid="bib51">2007</xref>; <xref ref-type="bibr" rid="bib79">Williams <italic>et al.</italic> 2007</xref>).</p>
<p>Trio acts as a RhoGEF for the small G protein Rho, a major cellular switch that affects a number of cellular processes ranging from regulation of the cytoskeleton to transcription (<xref ref-type="bibr" rid="bib20">Etienne-Manneville and Hall 2002</xref>; <xref ref-type="bibr" rid="bib30">Jaffe and Hall 2005</xref>). In <italic>C. elegans</italic> neurons, Rho regulates synaptic transmission downstream of the G<sub>12</sub>-class G protein GPA-12 via at least two pathways, one dependent on the diacylglycerol kinase DGK-1 and one independent of DGK-1 (<xref ref-type="bibr" rid="bib28">Hiley <italic>et al.</italic> 2006</xref>; <xref ref-type="bibr" rid="bib53">McMullan <italic>et al.</italic> 2006</xref>). Here, we investigate what targets act downstream of Rho in the G<sub>q</sub> signaling pathway to regulate neuronal activity. Through two forward genetic screens, we identify the cation channels NCA-1 and NCA-2 (NALCN in mammals) as downstream targets of the G<sub>q</sub>-Rho pathway. The NALCN<!-- Q7 --> channel is a relative of voltage-gated cation channels that has been suggested to be a sodium leak channel required for the propagation of neuronal excitation and the fidelity of synaptic transmission (<xref ref-type="bibr" rid="bib32">Jospin <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib45">Lu <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib81">Yeh <italic>et al.</italic> 2008</xref>)<!-- DBComment7 -->. However, there is controversy over whether NALCN is indeed a sodium leak channel (<xref ref-type="bibr" rid="bib65">Senatore and Spafford 2013</xref>; <xref ref-type="bibr" rid="bib66">Senatore <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib9">Boone <italic>et al.</italic> 2014</xref>). It is also unclear how NALCN is gated and what pathways activate the channel. Two studies have shown that NALCN-dependent currents can be activated by G protein-coupled receptors (GPCRs), albeit independently of G proteins (<xref ref-type="bibr" rid="bib46">Lu <italic>et al.</italic> 2009</xref>; <xref ref-type="bibr" rid="bib70">Swayne <italic>et al.</italic> 2009</xref>), and another study showed that the NALCN leak current can be activated by low extracellular calcium via a G protein-dependent pathway (<xref ref-type="bibr" rid="bib47">Lu <italic>et al.</italic> 2010</xref>). Our data here suggest that the worm NALCN orthologs NCA-1 and NCA-2 are activated by Rho acting downstream of G<sub>q</sub> in a linear pathway.</p>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2">
<title>Strains</title>
<p>Worm strains were cultured using standard methods (Brenner 1974). A complete list of strains<!-- Q8 --> and mutations is provided in the strain list (Supplemental Material, <ext-link ext-link-type="uri" xlink:href="http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.198820/-/DC1/TableS1.pdf">Table S1</ext-link>)<!-- DBComment8 -->.</p>
</sec>
<sec id="s3">
<title>Isolation of suppressors of activated G<sub>q</sub></title>
<p>We performed an ENU mutagenesis to screen for suppressors of the hyperactive locomotion of an activated G<sub>q</sub> mutant, <italic>egl-30(tg26)</italic> (<xref ref-type="bibr" rid="bib2">Ailion <italic>et al.</italic> 2014</xref>). From &#x223C;47,000 mutagenized haploid genomes, we isolated 10 mutants that had a fainter phenotype when outcrossed away from the <italic>egl-30(tg26)</italic> mutation. By mapping and complementation testing, we assigned these 10 mutants to three genes: three <italic>unc-79</italic> mutants (<italic>yak37</italic>, <italic>yak61</italic>, and <italic>yak73</italic>), six <italic>unc-80</italic> mutants (<italic>ox329</italic>, <italic>ox330</italic>, <italic>yak8</italic>, <italic>yak35</italic>, <italic>yak36</italic>, and <italic>yak56</italic>), and 1 <italic>nlf-1</italic> mutant (<italic>ox327</italic>). Complementation tests of <italic>ox329</italic> and <italic>ox330</italic> were performed by crossing heterozygous mutant males to <italic>unc-79(e1068)</italic> and <italic>unc-13(n2813) unc-80(ox301)</italic> hermaphrodites. Complementation tests of <italic>yak</italic> alleles were performed by crossing heterozygous mutant males (<italic>m/+</italic>) to <italic>unc-79(e1068)</italic> and <italic>unc-80(ox330)</italic> mutant hermaphrodites. We assessed the fainting phenotype of at least five male or hermaphrodite cross-progeny by touching animals on the head and scoring whether animals fainted within 5 sec. Control crosses with wild-type males demonstrated that <italic>unc-79/+</italic> and <italic>unc-80/+</italic> heterozygous males and hermaphrodites are phenotypically wild-type, demonstrating that these mutants are fully recessive.</p>
</sec>
<sec id="s4">
<title>Isolation of suppressors of activated G<sub>o</sub></title>
<p>We first isolated suppressors of the activated G<sub>o</sub> mutant <italic>unc-109(n499)</italic> by building double mutants of <italic>unc-109(n499)</italic> with the activated G<sub>q</sub> allele <italic>egl-30(tg26)</italic>. Unlike <italic>unc-109(n499)</italic> homozygotes, which are lethal, <italic>egl-30(tg26) unc-109(n499)</italic> homozygotes are viable, but paralyzed and sterile, indicating that activated G<sub>q</sub> partially suppresses activated G<sub>o</sub>. We built a balanced heterozygote strain <italic>egl-30(tg26) unc-109(n499)/egl-30(tg26) unc-13(e51) gld-1(q126)</italic> in which the worms move infrequently and slowly. We mutagenized these heterozygous animals with ENU and screened for F1 progeny that moved better. From a screen of &#x223C;16,000 mutagenized haploid genomes, we isolated two apparent <italic>unc-109</italic> intragenic mutants, <italic>ox303</italic> and <italic>ox304</italic>. <italic>ox303</italic> is a strong <italic>unc-109</italic> loss-of-function allele, as evidenced by the fact that <italic>egl-30(tg26) unc-109(n499 ox303)/egl-30(tg26) unc-13(e51) gld-1(q126)</italic> mutants resembled <italic>egl-30(tg26)</italic> mutants (<italic>i.e.</italic>, were hyperactive). Additionally, <italic>unc-109(n499 ox303)</italic> mutants are hyperactive. However, <italic>ox304</italic> appears to be a partial loss-of-function mutant, because the <italic>egl-30(tg26) unc-109(n499 ox304)/egl-30(tg26) unc-13(e51) gld-1(q126)</italic> mutant is not hyperactive like the <italic>egl-30(tg26)</italic> strain. Also, <italic>unc-109(n499 ox304)</italic> homozygote animals are viable, show very little spontaneous movement, and have a straight posture. However, when stimulated by transfer to a new plate, they are capable of coordinated movements. This strain was used for mapping and sequencing experiments that demonstrated that <italic>unc-109</italic> is allelic to <italic>goa-1</italic>, encoding the worm G<sub>o</sub> ortholog (see below). The <italic>unc-109(n499 ox304)</italic> strain was also used as the starting point for a second screen to isolate extragenic suppressors of activated G<sub>o</sub>.</p>
<p>Previously, a screen for suppressors of activated <italic>goa-1</italic> was performed using heat shock-induced expression of an activated <italic>goa-1</italic> transgene (<xref ref-type="bibr" rid="bib26">Hajdu-Cronin <italic>et al.</italic> 1999</xref>). This screen isolated many alleles of <italic>dgk-1</italic>, encoding DGK, and a single allele of <italic>eat-16</italic>, encoding a regulator of G protein signaling (RGS) protein that negatively regulates G<sub>q</sub> (<xref ref-type="bibr" rid="bib26">Hajdu-Cronin <italic>et al.</italic> 1999</xref>). Because of the strong bias of this screen for isolating alleles of <italic>dgk-1</italic>, we used the <italic>goa-1(n499 ox304</italic>) strain to perform a screen for suppressors of activated G<sub>o</sub> that did not involve overexpression of <italic>goa-1</italic>. We performed ENU mutagenesis of <italic>goa-1(n499 ox304</italic>) and isolated F2 animals that were not paralyzed. From a screen of &#x223C;24,000 mutagenized haploid genomes, we isolated 17 suppressors, nine with a relatively stronger suppression phenotype and eight that were weaker. Of the nine stronger suppressors, we isolated two alleles of <italic>eat-16</italic> (<italic>ox359</italic> and <italic>ox360</italic>), three alleles of the BK type potassium channel <italic>slo-1</italic> (<italic>ox357</italic>, <italic>ox358</italic>, and <italic>ox368</italic>), one allele of the gap junction innexin <italic>unc-9</italic> (<italic>ox353</italic>), one gain-of-function allele in the ion channel gene <italic>nca-1</italic> (<italic>ox352</italic>), and two mutants that were not assigned to genes (<italic>ox356</italic> and <italic>ox364</italic>).</p>
</sec>
<sec id="s5">
<title>Mapping and cloning <italic>nlf-1(ox327)</italic></title>
<p>We mapped the <italic>ox327</italic> mutation using single nucleotide polymorphisms (SNPs) in the Hawaiian strain CB4856 as described (<xref ref-type="bibr" rid="bib17">Davis <italic>et al.</italic> 2005</xref>). <italic>ox327</italic> was mapped to an &#x223C;459-kb region on the left arm of the X chromosome between SNPs on cosmids F39H12 and C52B11 (SNPs F39H12[4] and pkP6101). This region included 74 predicted protein-coding genes. We injected cosmids spanning this region and found that cosmid F55A4 rescued the <italic>ox327</italic> mutant phenotype. We performed RNA interference (RNAi) to the genes on this cosmid in the <italic>eri-1(mg366) lin-15(n744)</italic> strain, which has enhanced RNAi, and found that RNAi of the gene F55A4.2 caused a weak fainter phenotype. We sequenced F55A4.2 in the <italic>ox327</italic> mutant and found a T to A transversion mutation in exon 1, leading to a stop codon at amino acid C59. We also rescued the <italic>ox327</italic> mutant with a transgene carrying only F55A4.2. We subsequently obtained a deletion allele, <italic>tm3631</italic>, that has fainter and G<sub>q</sub> suppression phenotypes indistinguishable from <italic>ox327</italic>. F55A4.2 was given the gene name <italic>nlf-1</italic> (<xref ref-type="bibr" rid="bib80">Xie <italic>et al.</italic> 2013</xref>).</p>
<p>We obtained six independent <italic>nlf-1</italic> complementary DNAs (cDNAs) that were predicted to be full-length: yk1105g4, yk1159a2, yk1188d11, yk1279a1, yk1521f8, and yk1709b10. Restriction digests suggested that all six were of the same size. We sequenced yk1159a2 and yk1279a1 and both gave the same <italic>nlf-1</italic> exon&#x2013;intron structure, which differed from the gene structure on WormBase WS253 in several ways: <italic>nlf-1</italic> is 4 bp shorter at the 3&#x2032;-end of exon 5, and has a new 154-bp exon (now exon 6) not predicted on WormBase. <italic>nlf-1</italic> consists of eight exons and is predicted to encode a protein of 438 aa (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). This is identical to the gene structure reported independently (<xref ref-type="bibr" rid="bib80">Xie <italic>et al.</italic> 2013</xref>). Both sequenced cDNAs had 5&#x2032;-UTRs of 64 bp, with yk1159a2 (but not yk1279a1) being <italic>trans</italic>-spliced to the SL1 splice leader, and 3&#x2032;-UTRs of 424 bp (yk1279a1) or 429 bp (yk1159a2). The yk1279a1 cDNA was mutation-free and was cloned into a Gateway entry vector for rescue experiments. The full-length sequence of the yk1279a1 <italic>nlf-1</italic> cDNA was deposited in GenBank under accession # KX808524.</p>
</sec>
<sec id="s6">
<title>Mapping and cloning <italic>unc-109(n499)</italic></title>
<p><italic>unc-109</italic> was shown to be allelic to <italic>goa-1</italic>. First, we performed SNP mapping of both <italic>unc-109(n499)</italic> and its intragenic revertant <italic>unc-109(n499 ox303)</italic> using the Hawaiian strain CB4856 (<xref ref-type="bibr" rid="bib17">Davis <italic>et al.</italic> 2005</xref>). These experiments mapped <italic>unc-109</italic> to an &#x223C;1-Mb region in the middle of chromosome I between SNPs on cosmids D2092 and T24B1 (SNPs CE1-15 and T24B1[1]). A good candidate in this region was <italic>goa-1</italic>. We showed that <italic>unc-109</italic> is <italic>goa-1</italic> by sequencing the three <italic>unc-109</italic> mutants: the gain-of-function allele <italic>n499</italic> carries a point mutation that leads to an R179C missense mutation, affecting a conserved arginine residue shown to be important for the GTPase activity of G proteins (<xref ref-type="bibr" rid="bib15">Coleman <italic>et al.</italic> 1994</xref>); the partial loss-of-function allele <italic>ox304</italic> carries a point mutation leading to a W259R missense mutation; and the strong loss-of-function allele <italic>ox303</italic> carries a 1-bp deletion that leads to a stop codon 32 aa from the C-terminal.</p>
</sec>
<sec id="s7">
<title>Molecular biology and transgenes</title>
<p>A complete list of constructs is provided in the plasmid list (<ext-link ext-link-type="uri" xlink:href="http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.198820/-/DC1/TableS2.pdf">Table S2</ext-link>). Most of the constructs were made using the three-slot multisite Gateway system (Invitrogen, Carlsbad, CA). For C3 transferase (C3T) constructs, a promoter, an FRT-mCherry-FRT-GFP cassette (pWD178), and the <italic>Clostridium botulinum</italic> C3T-<italic>unc-54</italic> 3&#x2032;-UTR (cloned into a Gateway entry vector from plasmid QT#99) were combined into the pDEST R4-R3 destination vector. For <italic>nlf-1</italic> tissue-specific rescue constructs, a promoter, the <italic>nlf-1</italic> coding sequence (genomic DNA or cDNA), and a C-terminal GFP tag were cloned along with the <italic>unc-54</italic> 3&#x2032;-UTR into the pDEST R4-R3 destination vector. Promoters used were <italic>nlf-1p</italic> (5.7 kb upstream of the ATG), <italic>rab-3p</italic> (all neurons), <italic>unc-17p</italic> (acetylcholine neurons), <italic>unc-17Hp</italic> (head acetylcholine neurons) (<xref ref-type="bibr" rid="bib27">Hammarlund <italic>et al.</italic> 2007</xref>), <italic>acr-2p</italic> (acetylcholine motor neurons), <italic>unc-17&#x03B2;p</italic> (acetylcholine motor neurons) (<xref ref-type="bibr" rid="bib12">Charlie <italic>et al.</italic> 2006</xref>), and <italic>glr-1p</italic> (glutamate receptor interneurons). Extrachromosomal arrays were made by standard transformation methods (<xref ref-type="bibr" rid="bib54">Mello <italic>et al.</italic> 1991</xref>). Constructs of interest were injected at 10 ng/&#x03BC;l with marker and carrier DNAs added to make a final total concentration of at least 100 ng/&#x03BC;l. For most constructs, we isolated multiple independent insertions that behaved similarly. C3T extrachromosomal arrays were integrated into the genome using X-ray irradiation (4000 rad). Integrated transgenes were mapped to chromosomes and outcrossed twice.</p>
</sec>
<sec id="s8">
<title>Locomotion assays</title>
<p>We performed two different assays to measure locomotion. Body bend assays measured the rate of locomotion. Radial locomotion assays measured the radial distance animals moved from a point in a given unit of time, which provides a combined measurement of different aspects of locomotion including the rate of locomotion, waveform, and frequency of reversals. Both types of assays were performed on 10-cm plates seeded with thin lawns of OP50 bacteria. Plates were prepared by seeding 1.5 ml of stationary phase OP50 bacteria to cover the plate surface and growing the bacteria for 2 days at room temperature. Seeded plates were stored at 4&#x00B0; for up to 1 month. For body bend assays, first-day adult worms were picked to an assay plate, allowed to rest for 30 sec, and then body bends were counted for 1 min. A body bend was defined as the movement of the worm from maximum to minimum amplitude of the sine wave (<xref ref-type="bibr" rid="bib56">Miller <italic>et al.</italic> 1999</xref>). To minimize variation, all animals in an experiment were assayed on the same plate. For radial locomotion assays, five to eight first-day adults were picked together to the center of a plate to begin the assay (time 0). Positions of the worms were marked on the lid of the plate every 10 min for up to 40 min. Following the assay, the distance of each point to the center was measured. For most strains, radial distances did not increase after the first 10 min of the assay and all data presented here are for the 10-min time point. For all locomotion assays, the experimenter was blind to the genotypes of the strains assayed.</p>
<p>For Rho inhibition experiments (<xref ref-type="fig" rid="fig1">Figure 1</xref>), expression of C3T was induced by FLP-mediated recombination. Expression of FLP was induced by heat shock for 1 hr at 34&#x00B0;, plates were returned to room temperature, and animals were scored for locomotion 4 hr after the end of the heat shock period. For heat shock induction of activated Rho (<xref ref-type="fig" rid="fig8">Figure 8</xref>), worms were heat-shocked for 1 hr at 34&#x00B0;, returned to room temperature, and scored for locomotion 2 hr after the end of the heat shock period.</p>
<fig id="fig1" position="float" fig-type="figure"><label>Figure 1</label><caption><p>Inhibition of Rho in neurons suppresses an activated G<sub>q</sub> mutant. (A) Schematic of the FLP/FRT system we used for temporal and spatial expression of the Rho inhibitor C3 transferase (C3T). The transgene in the &#x201C;off&#x201D; configuration expresses the mCherry reporter under the control of the promoter sequence but terminates transcription in the <italic>let-858</italic> 3&#x2032;-UTR upstream of GFP-C3T. Expression of the FLP recombinase is induced by heat shock and leads to recombination between the FRT sites and deletion of the intervening <italic>mCherry</italic>::<italic>let-858</italic> 3&#x2032;-UTR fragment. This leads to transcription of GFP-C3T in the cells driven by the adjacent promoter. We used the pan-neuronal promoter <italic>rab-3p</italic>, acetylcholine neuron promoter <italic>unc-17p</italic>, and head acetylcholine neuron promoter <italic>unc-17Hp</italic>. (B) Inhibition of Rho by C3T in all adult neurons (<italic>rab-3p</italic> and <italic>oxIs412</italic> transgene), acetylcholine neurons (<italic>unc-17p</italic> and <italic>oxIs414</italic> transgene), or head acetylcholine neurons (<italic>unc-17Hp</italic> and <italic>oxIs434</italic> transgene) reduces the locomotion rate of wild-type (WT) animals. &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001, Dunnett&#x2019;s test. Error bars = SEM; <italic>n</italic> = 19&#x2013;20. (C) Inhibition of Rho in all adult neurons (<italic>rab-3p</italic> and <italic>oxIs412</italic> transgene) or acetylcholine neurons (<italic>unc-17p</italic> and <italic>oxIs414</italic> transgene) leads to a significant reduction in the rate of locomotion of the activated G<sub>q</sub> mutant <italic>egl-30(tg26)</italic> (Gq&#x002A;). Inhibition of Rho in head acetylcholine neurons (<italic>unc-17Hp</italic> and <italic>oxIs434</italic> transgene) leads to a small decrease in Gq&#x002A; locomotion that is not statistically significant. &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001; ns, not significant, <italic>P</italic> &#x003E; 0.05, Dunnett&#x2019;s test. Error bars = SEM; <italic>n</italic> = 10&#x2013;20. (D) Photos of first-day adult worms. The coiled body posture of the activated Gq&#x002A; mutant is suppressed by Rho inhibition in all neurons (<italic>rab-3p</italic>::<italic>C3T</italic>). (E) Photos of worm tracks. (F) Quantification of the track waveform. The loopy waveform of the activated Gq&#x002A; mutant is suppressed by Rho inhibition in all adult neurons (<italic>rab-3p</italic>::<italic>C3T</italic>) and partially suppressed by Rho inhibition in acetylcholine neurons (<italic>unc-17p</italic>::<italic>C3T</italic>). Rho inhibition in head acetylcholine (<italic>unc-17Hp</italic>::<italic>C3T</italic>) neurons does not suppress the loopy waveform of Gq&#x002A;. &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001; ns, not significant, <italic>P</italic> &#x003E; 0.05, Bonferroni test. All comparisons are to Gq&#x002A;. Error bars = SEM; <italic>n</italic> = 5.</p></caption><graphic xlink:href="gen.198820fig1"></graphic></fig>
</sec>
<sec id="s9">
<title>Fainting assays</title>
<p>Backward fainting times were measured by touching a worm on the head with a worm pick to stimulate movement and measuring the time to faint with a stopwatch. Forward fainting time was measured following a touch on the tail. Fainting was defined by an abrupt stop of movement along with a characteristic straightening of the head (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Alternatively, we touched worms on the head or tail with a pick and counted the number of body bends until the worm fainted. If a worm moved 10 body bends without fainting, we stopped the assay.</p>
</sec>
<sec id="s10">
<title>Waveform quantification</title>
<p>To quantify the track waveform, first-day adult animals were placed on an OP50 plate and allowed to move forward for a few seconds. We then imaged each animal&#x2019;s tracks using a Nikon (Garden City, NY) SMZ18 microscope with the DS-L3 camera control system. Track pictures were taken at 40 &#x00D7; and were processed using ImageJ. Period and 2 &#x00D7; amplitude were measured using the line tool. For each worm, five period/amplitude ratios were averaged. Five individual worms were used per experiment. We present the data for the period/amplitude because this metric is not strongly affected by the size of the animal and thus best captures the exaggerated &#x201C;loopy&#x201D; waveform of activated Gq and activated Rho mutants.</p>
<p>The loopy waveform of <italic>egl-30(tg26)</italic> mutants is also characterized by the head of the worm occasionally crossing over the body, leading the worm to form a figure-eight shape (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). This phenotype was quantified by placing animals on OP50 plates and allowing them to move forward, counting the number of times the head crossed over the body in 1 min.</p>
<fig id="fig2" position="float" fig-type="figure"><label>Figure 2</label><caption><p>Mutations affecting the NCA-1 and NCA-2 channels suppress the loopy waveform of the activated G<sub>q</sub> mutant <italic>egl-30(tg26)</italic> (Gq&#x002A;). (A) Photos of first-day adults. The <italic>unc-73(ox317)</italic>, <italic>unc-79(yak37)</italic>, and <italic>unc-80(ox330)</italic> mutations suppress the loopy waveform of Gq&#x002A;. (B) Photos of worm tracks. The photo of wild-type (WT) tracks is the same as the one shown in <xref ref-type="fig" rid="fig3">Figure 3C</xref>. (C) Quantification of the track waveform. The WT waveform data are the same data shown in <xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="fig" rid="fig6">Figure 6C</xref>, and <xref ref-type="fig" rid="fig9">Figure 9D</xref>. (D) Quantification of the worm&#x2019;s head crossing its body (&#x201C;crossovers&#x201D;). The <italic>nca-1(gk9)</italic> and <italic>nlf-1(ox327)</italic> mutations partially suppress the loopy waveform of Gq&#x002A; as measured by the crossover assay. Mutations in the canonical G<sub>q</sub> pathway such as <italic>egl-8(ox333)</italic> partially suppress and genes required for dense-core vesicle biogenesis such as <italic>rund-1(tm3622)</italic> do not significantly suppress the loopy waveform of Gq&#x002A;. The <italic>nca-2(gk5)</italic> mutation does not suppress Gq&#x002A;. &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001, &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01, &#x002A;<italic>P</italic> &#x003C; 0.05; ns, not significant, <italic>P</italic> &#x003E; 0.05, Bonferroni test. All comparisons are to Gq&#x002A;. Error bars = SEM; <italic>n</italic> = 5 (C); <italic>n</italic> = 6 (D).</p></caption><graphic xlink:href="gen.198820fig2"></graphic></fig>
</sec>
<sec id="s11">
<title>Imaging and image analysis</title>
<p>Worms were mounted on 2% agarose pads and anesthetized with sodium azide. Images were obtained using a Zeiss Pascal confocal microscope (Zeiss [Carl Zeiss], Thornwood, NY). For quantitative imaging of NCA-1::GFP and NCA-2::GFP (<ext-link ext-link-type="uri" xlink:href="http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.198820/-/DC1/FigureS1.pdf">Figure S1</ext-link>), Z-stack projections of the nerve ring axons on one side of the animal were collected and quantified in ImageJ as described (<xref ref-type="bibr" rid="bib32">Jospin <italic>et al.</italic> 2007</xref>). Dissecting microscope photographs of first-day adult worms were taken at 50 &#x00D7; using a Nikon SMZ18 microscope equipped with a DS-L3 camera control system.</p>
</sec>
<sec id="s12">
<title>Statistics</title>
<p><italic>P</italic>-values were determined using GraphPad Prism 5.0d (GraphPad Software). Normally distributed data sets with multiple comparisons were analyzed by a one-way ANOVA followed by a Bonferroni or Tukey <italic>post hoc</italic> test to examine selected comparisons, or by Dunnett&#x2019;s test if all comparisons were to the wild-type control. Nonnormally distributed data sets with multiple comparisons were analyzed by a Kruskal&#x2013;Wallis nonparametric ANOVA followed by Dunn&#x2019;s test to examine selected comparisons. Pairwise data comparisons were analyzed by a two-tailed unpaired <italic>t</italic>-test for normally distributed data or by a two-tailed Mann&#x2013;Whitney test for nonnormally distributed data.</p>
</sec>
<sec id="s13">
<title>Data availability</title>
<p>Strains and plasmids are shown in <ext-link ext-link-type="uri" xlink:href="http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.198820/-/DC1/TableS1.pdf">Table S1</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.198820/-/DC1/TableS2.pdf">Table S2</ext-link> and are available from the <italic>Caenorhabditis</italic> Genetics Center or upon request. The full-length sequence of the yk1279a1 <italic>nlf-1</italic> cDNA was deposited in GenBank under accession # KX808524. The authors state that all data necessary for confirming the conclusions presented in the article are represented fully within the article and Supplemental Material.</p>
</sec>
</sec>
<sec id="s14" sec-type="results">
<title>Results</title>
<sec id="s15">
<title>Inhibition of Rho suppresses activated G<sub>q</sub></title>
<p>Two pieces of data suggested that G<sub>q</sub> may regulate locomotion in <italic>C. elegans</italic> through activation of the small G protein Rho. First, both the hyperactive locomotion and tightly-coiled &#x201C;loopy&#x201D; body posture of the activated G<sub>q</sub> mutant <italic>egl-30(tg26)</italic> are suppressed by loss-of-function mutations in the <italic>unc-73</italic> RhoGEF Trio (<xref ref-type="bibr" rid="bib79">Williams <italic>et al.</italic> 2007</xref>). Second, expression of activated Rho causes worms to adopt a posture with a tightly-coiled waveform (<xref ref-type="bibr" rid="bib53">McMullan <italic>et al.</italic> 2006</xref>), reminiscent of the waveform of activated G<sub>q</sub> worms (<xref ref-type="bibr" rid="bib7">Bastiani <italic>et al.</italic> 2003</xref>; <xref ref-type="bibr" rid="bib2">Ailion <italic>et al.</italic> 2014</xref>). To determine whether G<sub>q</sub> signals through Rho, we tested whether Rho inhibition suppresses an activated G<sub>q</sub> mutant.</p>
<p>In <italic>C. elegans</italic>, there is a single gene encoding Rho (<italic>rho-1</italic>). Because loss of <italic>rho-1</italic> causes numerous pleiotropic developmental phenotypes and embryonic lethality (<xref ref-type="bibr" rid="bib31">Jantsch-Plunger <italic>et al.</italic> 2000</xref>), we employed the widely-used Rho inhibitor <italic>C. botulinum</italic> C3T, which ADP-ribosylates Rho (<xref ref-type="bibr" rid="bib3">Aktories <italic>et al.</italic> 2004</xref>). C3T has strong substrate specificity for Rho and has only weak activity toward other Rho family members like Rac and Cdc42 (<xref ref-type="bibr" rid="bib33">Just <italic>et al.</italic> 1992</xref>). Though effects of C3T on targets other than Rho cannot be absolutely excluded, a study in <italic>C. elegans</italic> found that C3T, <italic>rho-1</italic> RNAi, and expression of a dominant-negative form of Rho all caused similar defects in P cell migration (<xref ref-type="bibr" rid="bib68">Spencer <italic>et al.</italic> 2001</xref>). To bypass the developmental roles and study Rho function in the adult nervous system, we expressed C3T only in adult neurons by using the FLP recombinase/FRT system (<xref ref-type="bibr" rid="bib18">Davis <italic>et al.</italic> 2008</xref>). In this system, temporal control of C3T is achieved through induction of FLP via heat shock. FLP in turn promotes recombination between FRT sites to lead to expression of C3T in specific neurons (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We expressed C3T in the following classes of neurons: all neurons (<italic>rab-3p</italic>), acetylcholine neurons <italic>(unc-17p</italic>), head acetylcholine neurons (<italic>unc-17Hp</italic>), and acetylcholine motor neurons (<italic>unc-17&#x03B2;p</italic>). mCherry fluorescence confirmed expression in the expected neurons and GFP expression was used to monitor induction of C3T following FLP-mediated recombination.</p>
<p>Inhibition of <italic>rho-1</italic> in adult neurons caused a decreased locomotion rate (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). This effect was greatest when Rho was inhibited in all neurons, but Rho inhibition in acetylcholine subclasses of neurons also led to slower locomotion. Thus, Rho acts in multiple classes of neurons to promote locomotion in adult worms. In the absence of heat shock, all strains showed normal wild-type rates of locomotion and did not express any detectable GFP (data not shown), indicating that these transgenes do not provide leaky expression of C3T in the absence of heat shock. This confirms that Rho acts postdevelopmentally in mature neurons to regulate locomotion behavior (<xref ref-type="bibr" rid="bib53">McMullan <italic>et al.</italic> 2006</xref>).</p>
<p>To determine whether Rho acts downstream of G<sub>q</sub> signaling, we crossed the C3 transgenes into the background of the activated G<sub>q</sub> mutant <italic>egl-30(tg26)</italic>. Inhibition of <italic>rho-1</italic> in all adult neurons suppressed the loopy waveform, body posture, and hyperactive locomotion of the activated G<sub>q</sub> mutant (<xref ref-type="fig" rid="fig1">Figure 1, C&#x2013;F</xref>). Inhibition of <italic>rho-1</italic> in acetylcholine neurons suppressed the hyperactivity of activated G<sub>q</sub> (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), but only weakly suppressed the loopy waveform (<xref ref-type="fig" rid="fig1">Figure 1, D&#x2013;F</xref>). Thus, <italic>rho-1</italic> exhibits genetic interactions consistent with a role in the G<sub>q</sub> signaling pathway in both acetylcholine neurons and additional neurons.</p>
</sec>
<sec id="s16">
<title>Mutations in NCA channel subunits suppress activated G<sub>q</sub></title>
<p>What acts downstream of Rho in the G<sub>q</sub> signal transduction pathway? We screened for suppressors of activated G<sub>q</sub> and found mutants in three categories: (1) the canonical G<sub>q</sub> pathway (such as the PLC <italic>egl-8</italic>), (2) the RhoGEF <italic>unc-73</italic> (<xref ref-type="bibr" rid="bib79">Williams <italic>et al.</italic> 2007</xref>), and (3) genes that affect dense-core vesicle function (<italic>e.g.</italic>, <italic>unc-31</italic>, <italic>rab-2</italic>, and <italic>rund-1</italic>) (<xref ref-type="bibr" rid="bib2">Ailion <italic>et al.</italic> 2014</xref>; <xref ref-type="bibr" rid="bib71">Topalidou <italic>et al.</italic> 2016</xref>). Mutations in <italic>unc-73</italic> suppress the loopy waveform of the activated G<sub>q</sub> mutant more strongly than mutations in the canonical G<sub>q</sub> pathway or in genes that affect dense-core vesicle function (<xref ref-type="fig" rid="fig2">Figure 2, A, C, and D</xref>). Thus, stronger suppression of the loopy waveform of activated G<sub>q</sub> may be a characteristic of mutations in the Rho pathway.</p>
<p>To identify possible downstream targets of Rho in the G<sub>q</sub> pathway, we examined other mutants isolated from our screen for suppression of the loopy waveform of activated G<sub>q</sub> (<xref ref-type="fig" rid="fig2">Figure 2</xref>). When crossed away from the activating G<sub>q</sub> mutation, several of these mutants had a &#x201C;fainter&#x201D; phenotype. Fainter mutants respond to a touch stimulus by moving away, but abruptly stop, that is &#x201C;faint,&#x201D; after only a few body bends. The fainter phenotype has been observed only in mutants that reduce the function of the NCA-1 and NCA-2 ion channels (<xref ref-type="bibr" rid="bib29">Humphrey <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib32">Jospin <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib81">Yeh <italic>et al.</italic> 2008</xref>). We found that all our G<sub>q</sub> suppressors that strongly suppressed the loopy waveform and had a fainter phenotype were mutants in either <italic>unc-79</italic> or <italic>unc-80</italic>, two genes required for function of the NCA<!-- Q9 --> channels (<xref ref-type="bibr" rid="bib29">Humphrey <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib32">Jospin <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib81">Yeh <italic>et al.</italic> 2008</xref>)<!-- DBComment9 -->. We also isolated a single mutant in the gene <italic>nlf-1</italic> that also gave fainters after outcrossing away from the activated G<sub>q</sub> mutation, but did not strongly suppress the loopy waveform of the activated G<sub>q</sub> mutant (<xref ref-type="fig" rid="fig2">Figure 2</xref>). <italic>unc-79</italic> and <italic>unc-80</italic> mutants have a strong fainter phenotype equivalent to that of a double mutant in <italic>nca-1</italic> and <italic>nca-2</italic>, two genes that encode pore-forming subunits of the NCA channels in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib29">Humphrey <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib32">Jospin <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib81">Yeh <italic>et al.</italic> 2008</xref>). Like <italic>unc-79</italic> or <italic>unc-80</italic>, an <italic>nca-1 nca-2</italic> double mutant suppressed the activated G<sub>q</sub> mutant. Additionally, <italic>nca-1</italic> on its own partially suppressed activated G<sub>q</sub>, but <italic>nca-2</italic> did not (<xref ref-type="fig" rid="fig2">Figure 2</xref>). This suggests that although <italic>nca-1</italic> and <italic>nca-2</italic> are only redundantly required for normal worm locomotion, channels containing the NCA-1 pore-forming subunit have a larger role in transducing G<sub>q</sub> signals than NCA-2 channels.</p>
</sec>
<sec id="s17">
<title>Cloning and characterization of <italic>nlf-1(ox327)</italic></title>
<p>In addition to the previously known NCA channel subunits <italic>unc-79</italic> and <italic>unc-80</italic>, we also isolated the <italic>ox327</italic> mutant in a gene that had not been previously characterized at the time of our study. We cloned <italic>ox327</italic> by SNP mapping, RNAi, and transgenic rescue experiments (see <italic>Materials and Methods</italic>), showing that it carries an early stop mutation in the gene <italic>nlf-1</italic>. We sequenced two <italic>nlf-1</italic> cDNAs and found that its exon&#x2013;intron structure differed from the gene structure predicted on WormBase (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, see <italic>Materials and Methods</italic> for details). <italic>nlf-1</italic> was independently cloned by others (<xref ref-type="bibr" rid="bib80">Xie <italic>et al.</italic> 2013</xref>).</p>
<fig id="fig3" position="float" fig-type="figure"><label>Figure 3</label><caption><p>The <italic>nlf-1(ox327)</italic> mutation suppresses the coiled posture, loopy waveform, and locomotion defect of the activated NCA-1 mutant <italic>nca-1(ox352</italic>) (Nca&#x002A;). (A) Gene structure of <italic>nlf-1</italic>. Black boxes show coding segments. White boxes show 5&#x2032;- and 3&#x2032;-untranslated regions (UTRs). The <italic>ox327</italic> mutation leads to a premature stop codon at C59. The <italic>tm3631</italic> deletion removes most of the 5&#x2032;-UTR and first exon. (B) Photos of first-day adult worms. (C) Photos of worm tracks. The photo of wild-type (WT) tracks is the same as the one shown in <xref ref-type="fig" rid="fig2">Figure 2B</xref>. (D) Quantification of track waveform. The loopy waveform of Nca&#x002A; is suppressed by <italic>nlf-1</italic>. The WT data are the same data shown in <xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig6">Figure 6C</xref>, and <xref ref-type="fig" rid="fig9">Figure 9D</xref>. (E) Body bend assay. The WT data shown in the left graph are the same as shown in <xref ref-type="fig" rid="fig7">Figure 7A</xref>, right graph. (F) Radial locomotion assay. Statistics in (D): &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001, two-tailed unpaired <italic>t</italic>-test. Comparisons are to Nca&#x002A;. Error bars = SEM, <italic>n</italic> = 5. Statistics in (E) and (F): &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001, two-tailed Mann&#x2013;Whitney test. Error bars = SEM, <italic>n</italic> = 4&#x2013;10 (E), <italic>n</italic> = 8&#x2013;26 (F).</p></caption><graphic xlink:href="gen.198820fig3"></graphic></fig>
<p><italic>nlf-1</italic> encodes an endoplasmic reticulum-localized protein probably involved in proper assembly of the NCA channel, since <italic>nlf-1</italic> mutants had reduced expression levels of GFP-tagged NCA-1 and NCA-2 (<xref ref-type="bibr" rid="bib80">Xie <italic>et al.</italic> 2013</xref>). We also found that <italic>nlf-1</italic> is required for normal axonal levels of both GFP-tagged NCA-1 and NCA-2 in the nerve ring (<ext-link ext-link-type="uri" xlink:href="http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.198820/-/DC1/FigureS1.pdf">Figure S1</ext-link>). Additionally, an <italic>nlf-1</italic> mutation suppressed both the coiled posture and slow locomotion of an activated <italic>nca-1</italic> mutant (<xref ref-type="fig" rid="fig3">Figure 3, B&#x2013;F</xref>), demonstrating that <italic>nlf-1</italic> is important for NCA-1 function.</p>
<p><italic>nlf-1</italic> mutants have a weaker fainter phenotype than mutants of <italic>unc-79</italic> or <italic>unc-80</italic>, or the <italic>nca-1 nca-2</italic> double mutant (<xref ref-type="fig" rid="fig4">Figure 4, A and B</xref>), suggesting that <italic>nlf-1</italic> mutations cause a partial loss-of-function of the NCA channels. The <italic>nlf-1</italic> fainting phenotype differs in two ways from those of the stronger fainting mutants. First, <italic>nlf-1</italic> mutants take a longer time to faint following stimulation (<xref ref-type="fig" rid="fig4">Figure 4, A and B</xref>). Second, while the strong fainting mutants show a similarly strong fainting phenotype in either the forward or backward direction, <italic>nlf-1</italic> mutants faint reliably in the backward direction but have more variable fainting in the forward direction (<xref ref-type="fig" rid="fig4">Figure 4, A and B</xref>). Moreover, the <italic>nlf-1(ox327)</italic> mutation did not enhance the <italic>unc-79</italic> or <italic>unc-80</italic> fainter phenotype, suggesting that these mutants act in the same pathway to control fainting (<xref ref-type="fig" rid="fig4">Figure 4, C and D</xref>). However, <italic>nca-1</italic> strongly enhanced the <italic>nlf-1</italic> fainter phenotype, but <italic>nca-2</italic> did not significantly enhance <italic>nlf-1</italic> (<xref ref-type="fig" rid="fig4">Figure 4, A and B</xref>). Neither <italic>nca-1</italic> nor <italic>nca-2</italic> single mutants have a fainter phenotype on their own (<xref ref-type="bibr" rid="bib29">Humphrey <italic>et al.</italic> 2007</xref>), but the fact that an <italic>nca-1 nlf-1</italic> double mutant has a strong fainter phenotype suggests that either <italic>nca-1</italic> contributes more than <italic>nca-2</italic> for normal locomotion or that <italic>nlf-1</italic> specifically perturbs function of <italic>nca-2</italic>. Our data presented below are more consistent with the possibility that <italic>nca-1</italic> contributes more than <italic>nca-2</italic> to wild-type locomotion behavior.</p>
<fig id="fig4" position="float" fig-type="figure"><label>Figure 4</label><caption><p><italic>nlf-1</italic> mutants are weak fainters. The <italic>nlf-1(ox327)</italic> mutant is a weaker fainter in the forward direction (A) than the backward direction (B), but <italic>nlf-1(ox327)</italic> has a weaker fainter phenotype than either <italic>unc-80(ox330)</italic> or the <italic>nca-2(gk5)</italic>; <italic>nca-1(gk9)</italic> double mutant. Additionally, <italic>nlf-1</italic> mutants are enhanced by a mutation in <italic>nca-1</italic>, but not <italic>nca-2</italic>. Wild-type, <italic>nca-1(gk9)</italic>, and <italic>nca-2(gk5)</italic> mutant animals are not shown in the figure because they do not faint (0/10 animals fainted in a 1-min period). Also, <italic>nlf-1(ox327)</italic> mutants do not enhance the strong forward (C) or backward (D) fainting phenotypes of <italic>unc-79(e1068)</italic> and <italic>unc-80(ox330)</italic> mutants. &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001; ns, not significant, <italic>P</italic> &#x003E; 0.05, Dunn&#x2019;s test. Error bars = SEM; <italic>n</italic> = 10&#x2013;20.</p></caption><graphic xlink:href="gen.198820fig4"></graphic></fig>
<p>We determined the cellular expression pattern of <italic>nlf-1</italic> by fusing its promoter to GFP. <italic>nlf-1p</italic>::<italic>GFP</italic> was expressed in most or all neurons, but was not detected in other tissues (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). This agrees with the expression pattern reported elsewhere (<xref ref-type="bibr" rid="bib80">Xie <italic>et al.</italic> 2013</xref>). To determine the neuronal focus of the fainter phenotype, we performed rescue experiments in which we determined whether an <italic>nlf-1</italic> mutant could be rescued by expression of a wild-type <italic>nlf-1</italic> cDNA under the control of neuron-specific promoters. Expression of <italic>nlf-1(+)</italic> in all neurons (using the <italic>rab-3</italic> promoter) or acetylcholine neurons (using the <italic>unc-17</italic> promoter) fully rescued the <italic>nlf-1</italic> mutant fainter phenotype (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Expression in acetylcholine motor neurons (using the <italic>acr-2</italic> or <italic>unc-17&#x03B2;</italic> promoters) did not rescue the fainter phenotype, but expression driven by a head-specific derivative of the <italic>unc-17</italic> promoter (<italic>unc-17Hp</italic>) fully rescued the fainter phenotype, indicating that the action of <italic>nlf-1</italic> in head acetylcholine neurons is sufficient to prevent fainting (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p>
<fig id="fig5" position="float" fig-type="figure"><label>Figure 5</label><caption><p><italic>nlf-1</italic> acts in head acetylcholine neurons to control locomotion. (A) <italic>nlf-1</italic> is expressed widely in the nervous system. A fusion of the <italic>nlf-1</italic> promoter to GFP (transgene <italic>oxEx1144</italic>) is expressed throughout the nervous system. No expression is seen in nonneuronal tissues. An L1 stage larval animal is shown with its head to the left. (B and C) The <italic>nlf-1</italic> cDNA was expressed in an <italic>nlf-1(ox327)</italic> mutant background using the following promoters: <italic>rab-3</italic> (all neurons, <italic>oxEx1146</italic> transgene), <italic>unc-17</italic> (acetylcholine neurons, <italic>oxEx1149</italic> transgene), <italic>unc-17H</italic> (a derivative of the <italic>unc-17</italic> promoter that lacks the enhancer for ventral cord expression and thus expresses in head acetylcholine neurons and occasionally a few tail neurons, <italic>oxEx1155</italic> transgene), <italic>unc-17&#x03B2;</italic> (a derivative of the <italic>unc-17</italic> promoter that expresses only in ventral cord acetylcholine neurons, <italic>oxEx1323</italic> transgene), <italic>acr-2</italic> (ventral cord acetylcholine motor neurons, <italic>oxEx1151</italic> transgene), and <italic>glr-1</italic> (interneurons including premotor command interneurons, <italic>oxEx1152</italic> transgene). (B) Expression driven by the <italic>rab-3</italic>, <italic>unc-17</italic>, and <italic>unc-17H</italic> promoters rescued the fainting phenotype of an <italic>nlf-1</italic> mutant in the backward direction. &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001, Dunn&#x2019;s test. Error bars = SEM; <italic>n</italic> = 15. (C) Expression driven by the <italic>glr-1</italic> promoter partially rescued the fainting phenotype of an <italic>nlf-1</italic> mutant in either the backward or forward direction, though the effect was not statistically significant (ns, <italic>P</italic> &#x003E; 0.05, two-tailed Mann&#x2013;Whitney tests; Error bars = SEM, <italic>n</italic> = 25). However, assays of this strain were complicated by slow movement and frequent pauses that were hard to distinguish from true fainting behavior (see text for details). ns, not significant; WT, wild-type.</p></caption><graphic xlink:href="gen.198820fig5"></graphic></fig>
<p>Previously, it was reported that expression of <italic>nlf-1</italic> in premotor interneurons is sufficient to rescue the <italic>nlf-1</italic> mutant fainter phenotype (<xref ref-type="bibr" rid="bib80">Xie <italic>et al.</italic> 2013</xref>). However, we found that <italic>nlf-1</italic> mutant animals expressing <italic>nlf-1</italic> in premotor interneurons using the <italic>glr-1</italic> promoter (<italic>glr-1p</italic>) had sluggish movement and stopped frequently, though generally not with the characteristic posture typical of fainters, and we saw only weak rescue in our quantitative fainting assays that was not statistically significant (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). When we instead measured fainting as the percentage of animals that fainted within 10 body bends, we did see a marginally significant rescue by <italic>glr-1</italic> promoter expression (backward fainting: <italic>nlf-1</italic> = 92%, <italic>nlf-1</italic>; <italic>glr-1p</italic>::<italic>nlf-1(+)</italic> = 68%, <italic>P</italic> = 0.0738, Fisher&#x2019;s exact test; forward fainting: <italic>nlf-1</italic> = 80%, <italic>nlf-1</italic>; <italic>glr-1p</italic>::<italic>nlf-1(+)</italic> = 48%, <italic>P</italic> = 0.0378, Fisher&#x2019;s exact test). We may be underestimating the rescue of the fainting phenotype by <italic>glr-1</italic> promoter expression due to the difficulty distinguishing the frequent pausing from true fainting. Nevertheless, rescue of the <italic>nlf-1</italic> mutant is clearly stronger by expression in head acetylcholine neurons using the <italic>unc-17H</italic> promoter (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Although our data seem to contradict the previous study reporting that <italic>nlf-1</italic> acts in premotor interneurons (<xref ref-type="bibr" rid="bib80">Xie <italic>et al.</italic> 2013</xref>), there are several possible explanations. First, like our data, the data in the previous study in fact showed only partial rescue of fainting behavior by expression in premotor interneurons (<xref ref-type="bibr" rid="bib80">Xie <italic>et al.</italic> 2013</xref>). Second, the premotor interneuron promoter combination used in the previous study (<italic>nmr-1p</italic> + <italic>sra-11p</italic>) leads to expression in several other head interneurons that may contribute to the phenotype. Third, it is possible that rescue is sensitive to expression level and that different levels of expression were achieved in the two studies, leading to different levels of rescue. We conclude that NLF-1 acts in head acetylcholine neurons, including the premotor interneurons, to promote sustained locomotion in the worm. Consistent with this, the premotor command interneurons have recently been shown to use acetylcholine as a neurotransmitter (<xref ref-type="bibr" rid="bib59">Pereira <italic>et al.</italic> 2015</xref>).</p>
</sec>
<sec id="s18">
<title>Mutations in NCA channel subunits suppress activated Rho</title>
<p>To determine whether NCA mutants act downstream of Rho, we took advantage of an activated Rho mutant (G14V) expressed specifically in the acetylcholine neurons (<xref ref-type="bibr" rid="bib53">McMullan <italic>et al.</italic> 2006</xref>). Like an activated G<sub>q</sub> mutant, this activated Rho mutant has a loopy waveform. We built double mutants of the activated Rho mutant with mutations in <italic>unc-79</italic>, <italic>unc-80</italic>, <italic>nlf-1</italic>, and mutations in the NCA channel genes <italic>nca-1</italic> and <italic>nca-2</italic>. We found that the loopy waveform caused by activated Rho was suppressed in <italic>unc-80</italic> mutants, as well as in <italic>nca-1 nca-2</italic> double mutants (<xref ref-type="fig" rid="fig6">Figure 6</xref>). In both cases, the resulting double or triple mutants had a fainter phenotype like the <italic>unc-80</italic> or <italic>nca-1 nca-2</italic> mutants on their own. By contrast, the loopy waveform of activated Rho was incompletely suppressed by a mutation in <italic>nlf-1</italic>, consistent with the <italic>nlf-1</italic> mutation causing only a partial loss of NCA channel function (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Reciprocally, activated Rho suppressed the weak fainter phenotype of an <italic>nlf-1</italic> mutant, again because Rho can act on NCA even in the absence of <italic>nlf-1</italic>. Additionally, a mutation in <italic>nca-1</italic> also partially suppressed the loopy waveform of activated Rho, but a mutation in <italic>nca-2</italic> did not (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Thus, channels containing the NCA-1 pore-forming subunit have a larger role than NCA-2 channels in transducing Rho signals, similar to the interaction of NCA-1 and G<sub>q</sub> signaling.</p>
<fig id="fig6" position="float" fig-type="figure"><label>Figure 6</label><caption><p>Mutations in NCA channel subunits suppress the loopy waveform of animals expressing activated Rho. (A) Photos of first-day adult worms. Mutants in <italic>unc-80</italic>, <italic>nlf-1</italic>, and the <italic>nca-2 nca-1</italic> double mutant have the typical fainter posture characterized by a straightened anterior part of the body. Animals expressing an activated Rho mutant (G14V) in acetylcholine neurons (<italic>nzIs29</italic> transgene, written as Rho&#x002A;) have a loopy waveform. Mutations that eliminate NCA-1 and NCA-2 channel function (<italic>unc-80(ox330)</italic> or <italic>nca-2(gk5)</italic>; <italic>nca-1(gk9)</italic>) suppress the loopy waveform of activated Rho and convert the activated Rho mutants to fainters. Mutations in <italic>nlf-1(ox327)</italic> and <italic>nca-1(gk9)</italic> strongly but incompletely suppress the loopy waveform of activated Rho and these double mutants do not faint. Mutations in <italic>nca-2(gk5)</italic> do not suppress the loopy waveform of activated Rho. (B) Photos of worm tracks. (C) Quantification of track waveform. The wild-type (WT) data are the same data shown in <xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig3">Figure 3D</xref>, and <xref ref-type="fig" rid="fig9">Figure 9D</xref>. &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001, &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01; ns, not significant, <italic>P</italic> &#x003E; 0.05, Bonferroni test. All comparisons are to Rho&#x002A;. Error bars = SEM; <italic>n</italic> = 5.</p></caption><graphic xlink:href="gen.198820fig6"></graphic></fig>
<p>Because an activated Rho mutant has slow locomotion (<xref ref-type="fig" rid="fig7">Figure 7A</xref>) and <italic>unc-79</italic>, <italic>unc-80</italic>, and <italic>nca-1 nca-2</italic> double mutants also have slow locomotion, it is difficult to determine whether these NCA channel mutants suppress the locomotion phenotype of activated Rho in addition to its waveform. We performed radial locomotion assays that provide a combined measurement of several aspects of the locomotion phenotype, including the rate of movement and loopiness of the waveform (see <italic>Materials and Methods</italic>). By these assays, mutations in <italic>unc-80</italic> or <italic>nca-1 nca-2</italic> lead to only small increases in the radial distance traveled by an activated Rho mutant and an <italic>nca-2</italic> mutant had no effect (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). However, a mutation in <italic>nlf-1</italic> much more strongly increased the radial distance traveled by an activated Rho mutant. Because the <italic>nlf-1</italic> mutant is not as slow on its own, we could also directly assay its effect on the rate of locomotion of an activated Rho mutant by counting the number of body bends per minute. An <italic>nlf-1</italic> mutation strongly increased the rate of locomotion of an activated Rho mutant (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). In fact, the <italic>nlf-1</italic> double mutant with activated Rho had a faster rate of locomotion than either activated Rho or <italic>nlf-1</italic> on its own, similar to the effect of <italic>nlf-1</italic> on the locomotion of an activated <italic>nca-1</italic> mutant (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Additionally, a mutation in <italic>nca-1</italic> strongly increased the locomotion rate of the activated Rho mutant, but a mutation in <italic>nca-2</italic> had no effect (<xref ref-type="fig" rid="fig7">Figure 7A</xref>), further supporting the idea that NCA channels consisting of the NCA-1 subunit act downstream of G<sub>q</sub> and Rho.</p>
<fig id="fig7" position="float" fig-type="figure"><label>Figure 7</label><caption><p>Mutations in <italic>nlf-1</italic> and <italic>nca-1</italic> suppress the locomotion defect of animals expressing activated Rho. (A) Animals expressing an activated Rho mutant (G14V) in acetylcholine neurons (<italic>nzIs29</italic> transgene, written as Rho&#x002A;) have a slow locomotion rate as measured by the number of body bends. The <italic>nlf-1(ox327)</italic> and <italic>nca-1(gk9)</italic> mutations, but not <italic>nca-2(gk5)</italic>, strongly suppress the slow locomotion rate of activated Rho. The wild-type data shown in the right graph are the same as shown in <xref ref-type="fig" rid="fig3">Figure 3E</xref>, left graph. (B) Animals expressing an activated Rho mutant (G14V) in acetylcholine neurons (Rho&#x002A;) have reduced locomotion as measured in radial locomotion assays. Mutations that eliminate function of the NCA channels (<italic>unc-80(ox330)</italic> or <italic>nca-2(gk5)</italic>; <italic>nca-1(gk9)</italic>) increase the radial distance traveled by activated Rho mutants, but the effect is small since <italic>unc-80</italic> and <italic>nca-2</italic>; <italic>nca-1</italic> mutants have reduced locomotion on their own. The <italic>nlf-1(ox327)</italic> mutation that partially reduces function of the NCA channels strongly suppresses the locomotion defect of activated Rho. In the particular radial locomotion experiment shown here, only five Rho&#x002A;; <italic>nca-1</italic> animals were assayed and they had a mean radial distance traveled of 2.4 mm, very similar to the mean radial distance of the Rho&#x002A; single mutant (2.0 mm, <italic>n</italic> = 18). However, in an independent experiment, the Rho&#x002A;; <italic>nca-1</italic> double mutant had a mean radial distance of 12.2 mm (<italic>n</italic> = 10) as compared to 3.5 mm for the Rho&#x002A; single mutant (<italic>n</italic> = 10). Thus, it is likely that <italic>nca-1</italic> does indeed suppress <italic>Rho&#x002A;</italic> in radial locomotion assays, but gave a negative result in the presented assay due to low <italic>n</italic>, possibly because these particular Rho&#x002A;; <italic>nca-1</italic> animals moved outward and returned to the center. &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001; ns, not significant, <italic>P</italic> &#x003E; 0.05, Bonferroni test. Error bars = SEM; <italic>n</italic> = 10&#x2013;16 (A); <italic>n</italic> = 5&#x2013;18 (B).</p></caption><graphic xlink:href="gen.198820fig7"></graphic></fig>
<p>Rho regulates worm locomotion independently of effects on development, as demonstrated by the fact that heat shock induction of an activated Rho transgene in adults leads to a loopy waveform similar to that seen in worms that express activated Rho in acetylcholine neurons (<xref ref-type="bibr" rid="bib53">McMullan <italic>et al.</italic> 2006</xref>). Consistent with the idea that NCA-1 acts downstream of Rho, mutations in the fainter genes <italic>unc-80</italic> and <italic>nlf-1</italic> suppress the loopy waveform phenotype of heat shock-induced activated Rho (<xref ref-type="fig" rid="fig8">Figure 8, A&#x2013;C</xref>). Additionally, <italic>nlf-1</italic> also suppresses the locomotion defect of heat shock-induced activated Rho (<xref ref-type="fig" rid="fig8">Figure 8D</xref>). Thus, Rho regulates worm locomotion via the NCA channels by acting in adults.</p>
<fig id="fig8" position="float" fig-type="figure"><label>Figure 8</label><caption><p>Mutations in NCA channel subunits suppress the loopy waveform and locomotion of adult animals expressing activated Rho. (A) Photos of first-day adult worms. Animals expressing an activated Rho mutant (G14V) only in adults by heat shock-induced expression (<italic>nzIs1</italic> transgene, <italic>hs</italic>::<italic>Rho&#x002A;</italic>) have a loopy waveform. The <italic>unc-80(ox330)</italic> and <italic>nlf-1(ox327)</italic> mutations strongly suppress the loopy waveform of activated Rho. <italic>unc-80</italic>, but not <italic>nlf-1</italic>, makes the activated Rho animals faint. (B) Photos of worm tracks. (C) Quantification of track waveform. (D) Body bend assay. The <italic>nlf-1(ox327)</italic> mutation suppresses the reduced locomotion rate of activated Rho. Statistics in (C): &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001, Bonferroni test. Error bars = SEM; <italic>n</italic> = 5. Statistics in (D): &#x002A;<italic>P</italic> = 0.0157, two-tailed unpaired <italic>t</italic>-test. Error bars = SEM; <italic>n</italic> = 18&#x2013;30. WT, wild-type.</p></caption><graphic xlink:href="gen.198820fig8"></graphic></fig>
</sec>
<sec id="s19">
<title>A dominant NCA-1 mutation suppresses activated G<sub>o</sub></title>
<p>In <italic>C. elegans</italic>, the G<sub>q</sub> pathway is opposed by signaling through the inhibitory G<sub>o</sub> protein GOA-1 (<xref ref-type="bibr" rid="bib26">Hajdu-Cronin <italic>et al.</italic> 1999</xref>; <xref ref-type="bibr" rid="bib56">Miller <italic>et al.</italic> 1999</xref>). Thus, loss-of-function mutants in <italic>goa-1</italic> are hyperactive and have a loopy waveform, similar to the gain-of-function G<sub>q</sub> mutant <italic>egl-30(tg26)</italic>. We found that the uncloned dominant mutant <italic>unc-109(n499)</italic>, which is paralyzed and resembles loss-of-function mutants in <italic>egl-30</italic> (<xref ref-type="bibr" rid="bib58">Park and Horvitz 1986</xref>), carries an activating mutation in <italic>goa-1</italic> (see <italic>Materials and Methods</italic>). The <italic>goa-1(n499)</italic> mutant is paralyzed as a heterozygote and is lethal as a homozygote (<xref ref-type="bibr" rid="bib58">Park and Horvitz 1986</xref>). We performed a screen for suppressors of <italic>goa-1(n499)</italic> and isolated a partial intragenic suppressor, <italic>goa-1(n499 ox304</italic>) (<italic>Materials and Methods</italic>). <italic>goa-1(n499 ox304)</italic> homozygote animals are viable but show very little spontaneous movement, with a straight posture and relatively flat waveform (<xref ref-type="fig" rid="fig9">Figure 9, C and D</xref>). However, when stimulated, the <italic>goa-1(n499 ox304)</italic> mutant is capable of slow coordinated movements (<xref ref-type="fig" rid="fig9">Figure 9, A and B</xref>).</p>
<fig id="fig9" position="float" fig-type="figure"><label>Figure 9</label><caption><p>An activated NCA-1 mutant suppresses the straight posture and relatively flat waveform of an activated GOA-1 mutant. The <italic>goa-1(n499 ox304)</italic> mutant (written as Go&#x002A;) has a strong movement defect as shown by a body bend assay (A) and a radial locomotion assay (B). &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001, &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01, two-tailed unpaired <italic>t</italic>-tests. Error bars = SEM; <italic>n</italic> = 10 (A); <italic>n</italic> = 18 (B). Also the <italic>goa-1(n499 ox304)</italic> mutant has a relatively straight posture (C) and flat waveform (D) that is suppressed by the <italic>nca-1(ox352)</italic> mutation (written as Nca&#x002A;). The wild-type (WT) waveform data are the same data shown in <xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig3">Figure 3D</xref>, and <xref ref-type="fig" rid="fig6">Figure 6C</xref>. &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.001, &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01, Bonferroni test. Comparisons are to Go&#x002A;. Error bars = SEM; <italic>n</italic> = 5&#x2013;6.</p></caption><graphic xlink:href="gen.198820fig9"></graphic></fig>
<p>We mutagenized the <italic>goa-1(n499 ox304</italic>) strain and screened for animals that were not paralyzed or did not have a straight posture. Among the suppressors, we isolated a mutant (<italic>ox352</italic>) that was found to be a dominant gain-of-function mutation in the <italic>nca-1</italic> gene (<xref ref-type="bibr" rid="bib8">Bend <italic>et al.</italic> 2016</xref>). The <italic>nca-1(ox352)</italic> mutant has a coiled posture and loopy waveform reminiscent of the activated G<sub>q</sub> and activated Rho mutants (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Furthermore, <italic>nca-1(ox352)</italic> suppresses the straight waveform of the activated G<sub>o</sub> mutant <italic>goa-1(n499 ox304)</italic> (<xref ref-type="fig" rid="fig9">Figure 9, C and D</xref>). Thus, activation of NCA-1 suppresses activated G<sub>o</sub> whereas loss of NCA-1 suppresses activated G<sub>q</sub>, both consistent with the model that G<sub>o</sub> inhibits G<sub>q</sub> and that NCA-1 is a downstream effector of the G<sub>q</sub> pathway.</p>
</sec>
</sec>
<sec id="s20" sec-type="discussion">
<title>Discussion</title>
<p>In this study, we identify the NCA-1 and NCA-2 ion channels as downstream effectors of the heterotrimeric G proteins G<sub>q</sub> and G<sub>o</sub>. G<sub>q</sub> activates the RhoGEF Trio and the small GTPase Rho. Rho then acts via an unknown mechanism to activate the NCA-1 and NCA-2 ion channels, which are required for normal neuronal activity and synaptic transmission in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib32">Jospin <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib81">Yeh <italic>et al.</italic> 2008</xref>; <xref ref-type="bibr" rid="bib80">Xie <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib25">Gao <italic>et al.</italic> 2015</xref>). Thus, this work identifies a new genetic pathway from G<sub>q</sub> to an ion channel that regulates neuronal excitability and synaptic release: G<sub>q</sub> &#x2192; RhoGEF &#x2192; Rho &#x2192; NCA channels (<xref ref-type="fig" rid="fig10">Figure 10</xref>). The NCA channels have not been previously identified as effectors of the G<sub>q</sub> pathway, so this pathway may give insight into how the NCA channels are activated or regulated.</p>
<fig id="fig10" position="float" fig-type="figure"><label>Figure 10</label><caption><p>Model. G<sub>q</sub> activates NCA-1 in a linear pathway via the RhoGEF Trio and small G protein Rho. G<sub>q</sub> activation of Trio and Rho is direct (solid arrow). Rho activation of the NCA-1 channel is likely to be indirect (dashed arrow). G<sub>o</sub> inhibits G<sub>q</sub> via the RGS protein EAT-16 (<xref ref-type="bibr" rid="bib26">Hajdu-Cronin <italic>et al.</italic> 1999</xref>). Thus, loss-of-function mutations in the channel pore-forming subunit NCA-1, its associated subunits UNC-79 and UNC-80, or the ER-localized NCA channel assembly factor NLF-1 suppress an activated G<sub>q</sub> mutant, whereas a gain-of-function activating mutation in NCA-1 suppresses an activated G<sub>o</sub> mutant. Though the NCA-1 channel has the greatest role in conveying G<sub>q</sub>-Rho signals, channels composed of the NCA-2 pore-forming subunit are also probably regulated by G<sub>q</sub> because elimination of both NCA-1 and NCA-2 is required to fully suppress activated G<sub>q</sub> and activated Rho mutants. RGS, regulator of G protein signaling; RhoGEF, Rho guanine nucleotide exchange factor.</p></caption><graphic xlink:href="gen.198820fig10"></graphic></fig>
<p>Previously, it has been demonstrated that activation of G<sub>o</sub>&#x03B1; GOA-1 activates the RGS protein EAT-16, which in turn inhibits G<sub>q</sub>&#x03B1; (<xref ref-type="bibr" rid="bib26">Hajdu-Cronin <italic>et al.</italic> 1999</xref>; <xref ref-type="bibr" rid="bib56">Miller <italic>et al.</italic> 1999</xref>). Loss of <italic>goa-1</italic> leads to hyperactive worms (<xref ref-type="bibr" rid="bib55">Mendel <italic>et al.</italic> 1995</xref>; <xref ref-type="bibr" rid="bib64">S&#x00E9;galat <italic>et al.</italic> 1995</xref>). Here, we identified an activated mutation in <italic>goa-1</italic> that causes animals to be paralyzed, closely resembling null mutations in the G<sub>q</sub>&#x03B1; gene <italic>egl-30</italic> (<xref ref-type="bibr" rid="bib11">Brundage <italic>et al.</italic> 1996</xref>). Suppressors of activated G<sub>o</sub> include loss-of-function mutations in the RGS EAT-16, and gain-of-function mutations in the NCA-1 channel, suggesting that activated G<sub>o</sub> inactivates G<sub>q</sub>, and could thereby indirectly inactivate the NCA-1 cation channel. Previously, it has been shown that lack of the depolarizing NCA cation currents can be suppressed by a compensatory loss of the hyperpolarizing potassium current from SLO-1 (<xref ref-type="bibr" rid="bib35">Kasap <italic>et al.</italic> 2017</xref>), or by loss of the gap junction proteins UNC-9 or UNC-7 (<xref ref-type="bibr" rid="bib63">Sedensky and Meneely 1987</xref>; <xref ref-type="bibr" rid="bib57">Morgan and Sedensky 1995</xref>; <xref ref-type="bibr" rid="bib10">Bouhours <italic>et al.</italic> 2011</xref>). This is consistent with our isolation of <italic>slo-1</italic> and <italic>unc-9</italic> mutants as suppressors of activated G<sub>o</sub>, since activation of G<sub>o</sub> also leads to reduced NCA activity.</p>
<p>Mutations that eliminate the NCA channels, such as <italic>unc-80</italic> or the <italic>nca-1 nca-2</italic> double mutant, suppress the locomotion and body posture phenotypes of an activated Rho mutant (<xref ref-type="fig" rid="fig6">Figure 6</xref>, <xref ref-type="fig" rid="fig7">Figure 7</xref>, and <xref ref-type="fig" rid="fig8">Figure 8</xref>), suggesting that NCA channels act downstream of Rho in a linear pathway. Additionally, channels composed of the pore-forming subunit NCA-1 may be the main targets of G<sub>q</sub>-Rho signaling. First, loss-of-function mutations in <italic>nca-1</italic> alone, but not <italic>nca-2</italic>, partially suppress activated G<sub>q</sub> and activated Rho mutants. Second, activating gain-of-function mutants of <italic>nca-1</italic> have phenotypes reminiscent of activated G<sub>q</sub> and activated Rho mutants, but no activated mutants in <italic>nca-2</italic> have been isolated. Third, loss-of-function mutations in <italic>nca-1</italic>, but not <italic>nca-2</italic>, enhance the weaker fainting phenotype of an <italic>nlf-1</italic> mutant that does not fully eliminate function of the NCA channels. Together, these data suggest that, although either NCA-1 or NCA-2 activity is sufficient for wild-type locomotion, NCA-1 is likely to be the main target of G protein regulation.</p>
<p>We characterized three locomotory behaviors in this manuscript: locomotion rate, waveform, and fainting. The G<sub>q</sub>-Rho-NCA pathway regulates all three behaviors, but our genetic epistasis and cell-specific rescue experiments suggest that these behaviors are differentially regulated and involve at least partially distinct sets of neurons. First, the hyperactive locomotion and loopy waveform phenotypes of the activated G<sub>q</sub> mutant are genetically separable, since they are differentially suppressed by mutations in the PLC&#x03B2; pathway and the Rho-NCA pathway. Mutations in the Rho-NCA pathway suppress both the locomotion rate and loopy waveform of activated G<sub>q</sub> whereas mutations in the PLC&#x03B2; pathway suppress the locomotion rate but only very weakly suppress the loopy waveform of activated G<sub>q</sub>. Thus, G<sub>q</sub> acts through both the PLC&#x03B2; pathway and the Rho-NCA pathway to regulate locomotion rate, but primarily through the Rho-NCA pathway to regulate the waveform of the animal. Second, we found that NLF-1 activity in head acetylcholine neurons is sufficient to fully rescue the fainting phenotype of an <italic>nlf-1</italic> mutant. However, inhibition of Rho in the head acetylcholine neurons did not suppress the loopy waveform of the activated G<sub>q</sub> mutant, but inhibition of Rho in all neurons did suppress. This suggests that Rho does not act solely in head acetylcholine neurons to regulate the waveform. Thus, the G<sub>q</sub>-Rho-NCA pathway acts in at least two different classes of neurons to regulate fainting and waveform.</p>
<p>It is not clear whether Rho activation of the NCA channels is direct or indirect. G<sub>q</sub> directly interacts with and activates the RhoGEF and Rho, as shown by the crystal structure of a complex between G<sub>q</sub>&#x03B1;, RhoGEF, and Rho (<xref ref-type="bibr" rid="bib51">Lutz <italic>et al.</italic> 2007</xref>). Rho is known to have many possible effectors and actions in cells (<xref ref-type="bibr" rid="bib20">Etienne-Manneville and Hall 2002</xref>; <xref ref-type="bibr" rid="bib30">Jaffe and Hall 2005</xref>). In <italic>C. elegans</italic> neurons, Rho has been previously shown to regulate synaptic transmission via at least two pathways, one involving a direct interaction of Rho with the DAG kinase DGK-1 and one that is DGK-1-independent (<xref ref-type="bibr" rid="bib53">McMullan <italic>et al.</italic> 2006</xref>). A candidate for the link between Rho and NCA is the type I phosphatidylinositol 4-phosphate 5-kinase (PIP5K), which synthesizes the lipid PIP2. PIP5K is an intriguing candidate for several reasons. First, activation of G<sub>q</sub> in mammalian cells has been shown to stimulate the membrane localization and activity of PIP5K via a mechanism that depends on Rho (<xref ref-type="bibr" rid="bib13">Chatah and Abrams 2001</xref>; <xref ref-type="bibr" rid="bib76">Weernink <italic>et al.</italic> 2004</xref>). Second, in <italic>C. elegans</italic>, mutations eliminating either the NCA channels (<italic>nca-1 nca-2</italic> double mutant) or their accessory subunits (<italic>unc-79</italic> or <italic>unc-80</italic>) suppress mutants in the PIP2 phosphatase synaptojanin (<italic>unc-26</italic>) and also suppress phenotypes caused by overexpression of the PIP5K gene <italic>ppk-1</italic> (<xref ref-type="bibr" rid="bib32">Jospin <italic>et al.</italic> 2007</xref>). Loss of a PIP2 phosphatase or overexpression of a PIP5K are both predicted to increase levels of PIP2. Because the loss of NCA channels suppresses the effects of too much PIP2, it is possible that excessive PIP2 leads to overactivation of NCA channels and that PIP2 might be part of the normal activation mechanism. There are numerous examples of ion channels that are regulated or gated by phosphoinositide lipids such as PIP2 (<xref ref-type="bibr" rid="bib6">Balla 2013</xref>), though PIP2 has not been shown to directly regulate NCA/NALCN.</p>
<p>The NCA/NALCN ion channel was discovered originally by bioinformatic sequence analyses (<xref ref-type="bibr" rid="bib41">Lee <italic>et al.</italic> 1999</xref>; <xref ref-type="bibr" rid="bib43">Littleton and Ganetzky 2000</xref>). It is conserved among all metazoan animals and is evolutionarily related to the family of voltage-gated sodium and calcium channels (<xref ref-type="bibr" rid="bib42">Liebeskind <italic>et al.</italic> 2012</xref>), forming a new branch in this superfamily. Although the cellular role of the NCA/NALCN channel and how it is gated are not well-understood, NALCN and its orthologs are expressed broadly in the nervous system in a number of organisms (<xref ref-type="bibr" rid="bib41">Lee <italic>et al.</italic> 1999</xref>; <xref ref-type="bibr" rid="bib39">Lear <italic>et al.</italic> 2005</xref>; <xref ref-type="bibr" rid="bib29">Humphrey <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib32">Jospin <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib45">Lu <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib81">Yeh <italic>et al.</italic> 2008</xref>; <xref ref-type="bibr" rid="bib48">Lu and Feng 2011</xref>; <xref ref-type="bibr" rid="bib49">Lutas <italic>et al.</italic> 2016</xref>). Moreover, mutations in this channel or its auxiliary subunits lead to defects in rhythmic behaviors in multiple organisms (<xref ref-type="bibr" rid="bib39">Lear <italic>et al.</italic> 2005</xref>, <xref ref-type="bibr" rid="bib40">2013</xref>; <xref ref-type="bibr" rid="bib32">Jospin <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib45">Lu <italic>et al.</italic> 2007</xref>; <xref ref-type="bibr" rid="bib61">Pierce-Shimomura <italic>et al.</italic> 2008</xref>; <xref ref-type="bibr" rid="bib81">Yeh <italic>et al.</italic> 2008</xref>; <xref ref-type="bibr" rid="bib80">Xie <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib22">Funato <italic>et al.</italic> 2016</xref>). Thus, NCA/NALCN is likely to play an important role in controlling membrane excitability. Additionally, NALCN currents have been reported to be activated by two different GPCRs, the muscarinic acetylcholine receptor and the substance P receptor, albeit in a G protein-independent fashion (<xref ref-type="bibr" rid="bib46">Lu <italic>et al.</italic> 2009</xref>; <xref ref-type="bibr" rid="bib70">Swayne <italic>et al.</italic> 2009</xref>), and by low extracellular calcium via a G protein-dependent pathway (<xref ref-type="bibr" rid="bib47">Lu <italic>et al.</italic> 2010</xref>). The latter study further showed that expression of an activated G<sub>q</sub> mutant inhibited the NALCN sodium leak current, suggesting that high extracellular calcium tonically inhibits NALCN via a G<sub>q</sub>-dependent pathway and that low extracellular calcium activates NALCN by relieving this inhibition (<xref ref-type="bibr" rid="bib47">Lu <italic>et al.</italic> 2010</xref>). By contrast, we find that G<sub>q</sub> activates the NCA channels in <italic>C. elegans</italic>, and we show that the NCA channels are physiologically relevant targets of a G<sub>q</sub> signaling pathway that acts through Rho.</p>
<p>In the last few years, both recessive and dominant human diseases characterized by a range of neurological symptoms including hypotonia, intellectual disability, and seizures, have been shown to be caused by mutations in either <italic>NALCN</italic> or <italic>UNC80</italic> (<xref ref-type="bibr" rid="bib4">Al-Sayed <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib36">K&#x00F6;ro&#x011F;lu <italic>et al.</italic> 2013</xref>; <xref ref-type="bibr" rid="bib5">Aoyagi <italic>et al.</italic> 2015</xref>; <xref ref-type="bibr" rid="bib14">Chong <italic>et al.</italic> 2015</xref>; <xref ref-type="bibr" rid="bib8">Bend <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib21">Fukai <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib23">Gal <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib34">Karakaya <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib44">Lozic <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib60">Perez <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib67">Shamseldin <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib69">Stray-Pedersen <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib72">Valkanas <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib75">Wang <italic>et al.</italic> 2016</xref>; <xref ref-type="bibr" rid="bib73">Vivero <italic>et al.</italic> 2017</xref>). Notably, dominant disease-causing mutations in the NALCN channel were modeled in worms and resemble either dominant activated or loss-of-function NCA mutants such as the ones we used in this study (<xref ref-type="bibr" rid="bib5">Aoyagi <italic>et al.</italic> 2015</xref>; <xref ref-type="bibr" rid="bib8">Bend <italic>et al.</italic> 2016</xref>). Human mutations in other components of the pathway we have described may cause similar clinical phenotypes.</p>
</sec>
<sec id="s21">
<title></title>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Shohei Mitani for the <italic>nlf-1(tm3631)</italic> mutant; Steve Nurrish for worm strains and plasmids carrying activated Rho or C3 transferase; Ken Miller for a plasmid with the <italic>unc-17&#x03B2;</italic> promoter; Wayne Davis for FLP/FRT plasmids; Yuji Kohara for cDNA clones; the Sanger Center for cosmids; Brooke Jarvie, Jill Hoyt, and Michelle Giarmarco for the isolation of <italic>unc-79</italic> and <italic>unc-80</italic> mutations in the G<sub>q</sub> suppressor screen; and Dana Miller for the use of her microscope and camera to take worm photographs. Some strains were provided by the <italic>Caenorhabditis</italic> Genetics Center, which is funded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD-010440). M.A. is an Ellison Medical Foundation New Scholar. E.M.J. is an Investigator of the Howard Hughes Medical Institute. This work was supported by NIH grants R00 MH-082109 to M.A and R01 NS-034307 to E.M.J.</p>
</ack>
<fn-group><fn id="fn1"><p>Supplemental material is available online at <ext-link ext-link-type="uri" xlink:href="http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.198820/-/DC1">www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.198820/-/DC1</ext-link>.</p></fn>
<fn id="fn2"><p><italic>Communicating editor: M. V. Sundaram</italic></p></fn>
</fn-group>
<fn-group>
<title>AUTHOR QUERIES</title>
<fn id="Q1" fn-type="other"><p>Please check the WormBase links throughout. A list of entities linked in this article is available at <ext-link ext-link-type="uri" xlink:href="http://textpresso-dev.caltech.edu/gsa/worm/entity_link_tables/198820.html">http://textpresso-dev.caltech.edu/gsa/worm/entity_link_tables/198820.html.</ext-link></p></fn>
<fn id="Q2" fn-type="other"><p>Please verify all Supplemental Material links in your article.</p></fn>
<fn id="Q3" fn-type="other"><p>Please confirm or update any and all URLs in your article.</p></fn>
<fn id="Q4" fn-type="other"><p>Please verify corresponding author address.</p></fn>
<fn id="Q5" fn-type="other"><p>Please check use of italics throughout your article, including all taxonomic and genetic nomenclature. GENETICS style uses italics for genes and alleles. Note that headings are set per journal style and should not be changed to italics or non-italics during proof review.</p></fn>
<fn id="Q6" fn-type="other"><p>Please shorten running title which must be no longer than 40 characters (including spaces).</p></fn>
<fn id="Q7" fn-type="other"><p>Please define abbreviation &#x201C;NALCN&#x201D; in full at first use in abstract and main text.</p></fn>
<fn id="Q8" fn-type="other"><p>Please add &#x201C;Brenner (1974)&#x201D; to Literature Cited or delete citation from text.</p></fn>
<fn id="Q9" fn-type="other"><p>If an abbreviation, please define &#x201C;NCA&#x201D; at first use.</p></fn></fn-group>
<ref-list>
<title>Literature Cited</title>
<ref id="bib1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>T.</given-names></name><name><surname>Kunitomo</surname><given-names>H.</given-names></name><name><surname>Tomioka</surname><given-names>M.</given-names></name><name><surname>Ohno</surname><given-names>H.</given-names></name><name><surname>Okochi</surname><given-names>Y.</given-names></name><etal/></person-group>, <year>2010</year>&#x2003;<article-title>Reversal of salt preference is directed by the insulin/PI3K and Gq/PKC signaling in Caenorhabditis elegans.</article-title> <source>Genetics</source> <volume>186</volume>: <fpage>1309</fpage>&#x2013;<lpage>1319</lpage>.</citation></ref>
<ref id="bib2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ailion</surname><given-names>M.</given-names></name><name><surname>Hannemann</surname><given-names>M.</given-names></name><name><surname>Dalton</surname><given-names>S.</given-names></name><name><surname>Pappas</surname><given-names>A.</given-names></name><name><surname>Watanabe</surname><given-names>S.</given-names></name><etal/></person-group>, <year>2014</year>&#x2003;<article-title>Two Rab2 interactors regulate dense-core vesicle maturation.</article-title> <source>Neuron</source> <volume>82</volume>: <fpage>167</fpage>&#x2013;<lpage>180</lpage>.</citation></ref>
<ref id="bib3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aktories</surname><given-names>K.</given-names></name><name><surname>Wilde</surname><given-names>C.</given-names></name><name><surname>Vogelsgesang</surname><given-names>M.</given-names></name></person-group>, <year>2004</year>&#x2003;<article-title>Rho-modifying C3-like ADP-ribosyltransferases.</article-title> <source>Rev. Physiol. Biochem. Pharmacol.</source> <volume>152</volume>: <fpage>1</fpage>&#x2013;<lpage>22</lpage>.</citation></ref>
<ref id="bib4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al-Sayed</surname><given-names>M. D.</given-names></name><name><surname>Al-Zaidan</surname><given-names>H.</given-names></name><name><surname>Albakheet</surname><given-names>A.</given-names></name><name><surname>Hakami</surname><given-names>H.</given-names></name><name><surname>Kenana</surname><given-names>R.</given-names></name><etal/></person-group>, <year>2013</year>&#x2003;<article-title>Mutations in NALCN cause an autosomal-recessive syndrome with severe hypotonia, speech impairment, and cognitive delay.</article-title> <source>Am. J. Hum. Genet.</source> <volume>93</volume>: <fpage>721</fpage>&#x2013;<lpage>726</lpage>.</citation></ref>
<ref id="bib5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aoyagi</surname><given-names>K.</given-names></name><name><surname>Rossignol</surname><given-names>E.</given-names></name><name><surname>Hamdan</surname><given-names>F. F.</given-names></name><name><surname>Mulcahy</surname><given-names>B.</given-names></name><name><surname>Xie</surname><given-names>L.</given-names></name><etal/></person-group>, <year>2015</year>&#x2003;<article-title>A gain-of-function mutation in NALCN in a child with intellectual disability, ataxia, and arthrogryposis.</article-title> <source>Hum. Mutat.</source> <volume>36</volume>: <fpage>753</fpage>&#x2013;<lpage>757</lpage>.</citation></ref>
<ref id="bib6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balla</surname><given-names>T.</given-names></name></person-group>, <year>2013</year>&#x2003;<article-title>Phosphoinositides: tiny lipids with giant impact on cell regulation.</article-title> <source>Physiol. Rev.</source> <volume>93</volume>: <fpage>1019</fpage>&#x2013;<lpage>1137</lpage>.</citation></ref>
<ref id="bib7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bastiani</surname><given-names>C. A.</given-names></name><name><surname>Gharib</surname><given-names>S.</given-names></name><name><surname>Simon</surname><given-names>M. I.</given-names></name><name><surname>Sternberg</surname><given-names>P. W.</given-names></name></person-group>, <year>2003</year>&#x2003;<article-title>Caenorhabditis elegans Galphaq regulates egg-laying behavior via a PLCbeta-independent and serotonin-dependent signaling pathway and likely functions both in the nervous system and in muscle.</article-title> <source>Genetics</source> <volume>165</volume>: <fpage>1805</fpage>&#x2013;<lpage>1822</lpage>.</citation></ref>
<ref id="bib8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bend</surname><given-names>E. G.</given-names></name><name><surname>Si</surname><given-names>Y.</given-names></name><name><surname>Stevenson</surname><given-names>D. A.</given-names></name><name><surname>Bayrak-Toydemir</surname><given-names>P.</given-names></name><name><surname>Newcomb</surname><given-names>T. M.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>NALCN channelopathies: distinguishing gain-of-function and loss-of-function mutations.</article-title> <source>Neurology</source> <volume>87</volume>: <fpage>1131</fpage>&#x2013;<lpage>1139</lpage>.</citation></ref>
<ref id="bib9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boone</surname><given-names>A. N.</given-names></name><name><surname>Senatore</surname><given-names>A.</given-names></name><name><surname>Chemin</surname><given-names>J.</given-names></name><name><surname>Monteil</surname><given-names>A.</given-names></name><name><surname>Spafford</surname><given-names>J. D.</given-names></name></person-group>, <year>2014</year>&#x2003;<article-title>Gd3+ and calcium sensitive, sodium leak currents are features of weak membrane-glass seals in patch clamp recordings.</article-title> <source>PLoS One</source> <volume>9</volume>: <fpage>e98808</fpage>.</citation></ref>
<ref id="bib10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bouhours</surname><given-names>M.</given-names></name><name><surname>Po</surname><given-names>M. D.</given-names></name><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Hung</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><etal/></person-group>, <year>2011</year>&#x2003;<article-title>A co-operative regulation of neuronal excitability by UNC-7 innexin and NCA/NALCN leak channel.</article-title> <source>Mol. Brain</source> <volume>4</volume>: <fpage>16</fpage>.</citation></ref>
<ref id="bib11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brundage</surname><given-names>L.</given-names></name><name><surname>Avery</surname><given-names>L.</given-names></name><name><surname>Katz</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>U. J.</given-names></name><name><surname>Mendel</surname><given-names>J. E.</given-names></name><etal/></person-group>, <year>1996</year>&#x2003;<article-title>Mutations in a C. elegans Gqalpha gene disrupt movement, egg laying, and viability.</article-title> <source>Neuron</source> <volume>16</volume>: <fpage>999</fpage>&#x2013;<lpage>1009</lpage>.</citation></ref>
<ref id="bib12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Charlie</surname><given-names>N. K.</given-names></name><name><surname>Schade</surname><given-names>M. A.</given-names></name><name><surname>Thomure</surname><given-names>A. M.</given-names></name><name><surname>Miller</surname><given-names>K. G.</given-names></name></person-group>, <year>2006</year>&#x2003;<article-title>Presynaptic UNC-31 (CAPS) is required to activate the G alpha(s) pathway of the Caenorhabditis elegans synaptic signaling network.</article-title> <source>Genetics</source> <volume>172</volume>: <fpage>943</fpage>&#x2013;<lpage>961</lpage>.</citation></ref>
<ref id="bib13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chatah</surname><given-names>N. E.</given-names></name><name><surname>Abrams</surname><given-names>C. S.</given-names></name></person-group>, <year>2001</year>&#x2003;<article-title>G-protein-coupled receptor activation induces the membrane translocation and activation of phosphatidylinositol-4-phosphate 5-kinase I alpha by a Rac- and Rho-dependent pathway.</article-title> <source>J. Biol. Chem.</source> <volume>276</volume>: <fpage>34059</fpage>&#x2013;<lpage>34065</lpage>.</citation></ref>
<ref id="bib14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>J. X.</given-names></name><name><surname>McMillin</surname><given-names>M. J.</given-names></name><name><surname>Shively</surname><given-names>K. M.</given-names></name><name><surname>Beck</surname><given-names>A. E.</given-names></name><name><surname>Marvin</surname><given-names>C. T.</given-names></name><etal/></person-group>, <year>2015</year>&#x2003;<article-title>De novo mutations in NALCN cause a syndrome characterized by congenital contractures of the limbs and face, hypotonia, and developmental delay.</article-title> <source>Am. J. Hum. Genet.</source> <volume>96</volume>: <fpage>462</fpage>&#x2013;<lpage>473</lpage>.</citation></ref>
<ref id="bib15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>D. E.</given-names></name><name><surname>Berghuis</surname><given-names>A. M.</given-names></name><name><surname>Lee</surname><given-names>E.</given-names></name><name><surname>Linder</surname><given-names>M. E.</given-names></name><name><surname>Gilman</surname><given-names>A. G.</given-names></name><etal/></person-group>, <year>1994</year>&#x2003;<article-title>Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis.</article-title> <source>Science</source> <volume>265</volume>: <fpage>1405</fpage>&#x2013;<lpage>1412</lpage>.</citation></ref>
<ref id="bib16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coulon</surname><given-names>P.</given-names></name><name><surname>Kanyshkova</surname><given-names>T.</given-names></name><name><surname>Broicher</surname><given-names>T.</given-names></name><name><surname>Munsch</surname><given-names>T.</given-names></name><name><surname>Wettschureck</surname><given-names>N.</given-names></name><etal/></person-group>, <year>2010</year>&#x2003;<article-title>Activity modes in thalamocortical relay neurons are modulated by G(q)/G(11) family G-proteins - serotonergic and glutamatergic signaling.</article-title> <source>Front. Cell. Neurosci.</source> <volume>4</volume>: <fpage>132</fpage>.</citation></ref>
<ref id="bib17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>M. W.</given-names></name><name><surname>Hammarlund</surname><given-names>M.</given-names></name><name><surname>Harrach</surname><given-names>T.</given-names></name><name><surname>Hullett</surname><given-names>P.</given-names></name><name><surname>Olsen</surname><given-names>S.</given-names></name><etal/></person-group>, <year>2005</year>&#x2003;<article-title>Rapid single nucleotide polymorphism mapping in C. elegans.</article-title> <source>BMC Genomics</source> <volume>6</volume>: <fpage>118</fpage>.</citation></ref>
<ref id="bib18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>M. W.</given-names></name><name><surname>Morton</surname><given-names>J. J.</given-names></name><name><surname>Carroll</surname><given-names>D.</given-names></name><name><surname>Jorgensen</surname><given-names>E. M.</given-names></name></person-group>, <year>2008</year>&#x2003;<article-title>Gene activation using FLP recombinase in C. elegans.</article-title> <source>PLoS Genet.</source> <volume>4</volume>: <fpage>e1000028</fpage>.</citation></ref>
<ref id="bib19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>G.</given-names></name><name><surname>Amoroso</surname><given-names>M. R.</given-names></name><name><surname>Bergamasco</surname><given-names>C.</given-names></name><name><surname>Di Schiavi</surname><given-names>E.</given-names></name><name><surname>Bazzicalupo</surname><given-names>P.</given-names></name></person-group>, <year>2010</year>&#x2003;<article-title>The G protein regulators EGL-10 and EAT-16, the Gi&#x03B1; GOA-1 and the G(q)&#x03B1; EGL-30 modulate the response of the C. elegans ASH polymodal nociceptive sensory neurons to repellents.</article-title> <source>BMC Biol.</source> <volume>8</volume>: <fpage>138</fpage>.</citation></ref>
<ref id="bib20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Etienne-Manneville</surname><given-names>S.</given-names></name><name><surname>Hall</surname><given-names>A.</given-names></name></person-group>, <year>2002</year>&#x2003;<article-title>Rho GTPases in cell biology.</article-title> <source>Nature</source> <volume>420</volume>: <fpage>629</fpage>&#x2013;<lpage>635</lpage>.</citation></ref>
<ref id="bib21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukai</surname><given-names>R.</given-names></name><name><surname>Saitsu</surname><given-names>H.</given-names></name><name><surname>Okamoto</surname><given-names>N.</given-names></name><name><surname>Sakai</surname><given-names>Y.</given-names></name><name><surname>Fattal-Valevski</surname><given-names>A.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>De novo missense mutations in NALCN cause developmental and intellectual impairment with hypotonia.</article-title> <source>J. Hum. Genet.</source> <volume>61</volume>: <fpage>451</fpage>&#x2013;<lpage>455</lpage>.</citation></ref>
<ref id="bib22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Funato</surname><given-names>H.</given-names></name><name><surname>Miyoshi</surname><given-names>C.</given-names></name><name><surname>Fujiyama</surname><given-names>T.</given-names></name><name><surname>Kanda</surname><given-names>T.</given-names></name><name><surname>Sato</surname><given-names>M.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>Forward-genetics analysis of sleep in randomly mutagenized mice.</article-title> <source>Nature</source> <volume>539</volume>: <fpage>378</fpage>&#x2013;<lpage>383</lpage>.</citation></ref>
<ref id="bib23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gal</surname><given-names>M.</given-names></name><name><surname>Magen</surname><given-names>D.</given-names></name><name><surname>Zahran</surname><given-names>Y.</given-names></name><name><surname>Ravid</surname><given-names>S.</given-names></name><name><surname>Eran</surname><given-names>A.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>A novel homozygous splice site mutation in NALCN identified in siblings with cachexia, strabismus, severe intellectual disability, epilepsy and abnormal respiratory rhythm.</article-title> <source>Eur. J. Med. Genet.</source> <volume>59</volume>: <fpage>204</fpage>&#x2013;<lpage>209</lpage>.</citation></ref>
<ref id="bib24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N.</given-names></name><name><surname>Reznikov</surname><given-names>V.</given-names></name><name><surname>Yamada</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Shapiro</surname><given-names>M. S.</given-names></name></person-group>, <year>2004</year>&#x2003;<article-title>Phosphatidylinositol 4,5-bisphosphate signals underlie receptor-specific Gq/11-mediated modulation of N-type Ca2+ channels.</article-title> <source>J. Neurosci.</source> <volume>24</volume>: <fpage>10980</fpage>&#x2013;<lpage>10992</lpage>.</citation></ref>
<ref id="bib25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>Kawano</surname><given-names>T.</given-names></name><name><surname>Po</surname><given-names>M. D.</given-names></name><name><surname>Pirri</surname><given-names>J. K.</given-names></name><etal/></person-group>, <year>2015</year>&#x2003;<article-title>The NCA sodium leak channel is required for persistent motor circuit activity that sustains locomotion.</article-title> <source>Nat. Commun.</source> <volume>6</volume>: <fpage>6323</fpage>.</citation></ref>
<ref id="bib26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hajdu-Cronin</surname><given-names>Y. M.</given-names></name><name><surname>Chen</surname><given-names>W. J.</given-names></name><name><surname>Patikoglou</surname><given-names>G.</given-names></name><name><surname>Koelle</surname><given-names>M. R.</given-names></name><name><surname>Sternberg</surname><given-names>P. W.</given-names></name></person-group>, <year>1999</year>&#x2003;<article-title>Antagonism between G(o)alpha and G(q)alpha in Caenorhabditis elegans: the RGS protein EAT-16 is necessary for G(o)alpha signaling and regulates G(q)alpha activity.</article-title> <source>Genes Dev.</source> <volume>13</volume>: <fpage>1780</fpage>&#x2013;<lpage>1793</lpage>.</citation></ref>
<ref id="bib27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hammarlund</surname><given-names>M.</given-names></name><name><surname>Palfreyman</surname><given-names>M. T.</given-names></name><name><surname>Watanabe</surname><given-names>S.</given-names></name><name><surname>Olsen</surname><given-names>S.</given-names></name><name><surname>Jorgensen</surname><given-names>E. M.</given-names></name></person-group>, <year>2007</year>&#x2003;<article-title>Open syntaxin docks synaptic vesicles.</article-title> <source>PLoS Biol.</source> <volume>5</volume>: <fpage>e198</fpage>.</citation></ref>
<ref id="bib28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiley</surname><given-names>E.</given-names></name><name><surname>McMullan</surname><given-names>R.</given-names></name><name><surname>Nurrish</surname><given-names>S. J.</given-names></name></person-group>, <year>2006</year>&#x2003;<article-title>The Galpha12-RGS RhoGEF-RhoA signalling pathway regulates neurotransmitter release in C. elegans.</article-title> <source>EMBO J.</source> <volume>25</volume>: <fpage>5884</fpage>&#x2013;<lpage>5895</lpage>.</citation></ref>
<ref id="bib29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Humphrey</surname><given-names>J. A.</given-names></name><name><surname>Hamming</surname><given-names>K. S.</given-names></name><name><surname>Thacker</surname><given-names>C. M.</given-names></name><name><surname>Scott</surname><given-names>R. L.</given-names></name><name><surname>Sedensky</surname><given-names>M. M.</given-names></name><etal/></person-group>, <year>2007</year>&#x2003;<article-title>A putative cation channel and its novel regulator: cross-species conservation of effects on general anesthesia.</article-title> <source>Curr. Biol.</source> <volume>17</volume>: <fpage>624</fpage>&#x2013;<lpage>629</lpage>.</citation></ref>
<ref id="bib30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaffe</surname><given-names>A. B.</given-names></name><name><surname>Hall</surname><given-names>A.</given-names></name></person-group>, <year>2005</year>&#x2003;<article-title>Rho GTPases: biochemistry and biology.</article-title> <source>Annu. Rev. Cell Dev. Biol.</source> <volume>21</volume>: <fpage>247</fpage>&#x2013;<lpage>269</lpage>.</citation></ref>
<ref id="bib31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jantsch-Plunger</surname><given-names>V.</given-names></name><name><surname>G&#x00F6;nczy</surname><given-names>P.</given-names></name><name><surname>Romano</surname><given-names>A.</given-names></name><name><surname>Schnabel</surname><given-names>H.</given-names></name><name><surname>Hamill</surname><given-names>D.</given-names></name><etal/></person-group>, <year>2000</year>&#x2003;<article-title>CYK-4: a Rho family gtpase activating protein (GAP) required for central spindle formation and cytokinesis.</article-title> <source>J. Cell Biol.</source> <volume>149</volume>: <fpage>1391</fpage>&#x2013;<lpage>1404</lpage>.</citation></ref>
<ref id="bib32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jospin</surname><given-names>M.</given-names></name><name><surname>Watanabe</surname><given-names>S.</given-names></name><name><surname>Joshi</surname><given-names>D.</given-names></name><name><surname>Young</surname><given-names>S.</given-names></name><name><surname>Hamming</surname><given-names>K.</given-names></name><etal/></person-group>, <year>2007</year>&#x2003;<article-title>UNC-80 and the NCA ion channels contribute to endocytosis defects in synaptojanin mutants.</article-title> <source>Curr. Biol.</source> <volume>17</volume>: <fpage>1595</fpage>&#x2013;<lpage>1600</lpage>.</citation></ref>
<ref id="bib33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Just</surname><given-names>I.</given-names></name><name><surname>Mohr</surname><given-names>C.</given-names></name><name><surname>Schallehn</surname><given-names>G.</given-names></name><name><surname>Menard</surname><given-names>L.</given-names></name><name><surname>Didsbury</surname><given-names>J. R.</given-names></name><etal/></person-group>, <year>1992</year>&#x2003;<article-title>Purification and characterization of an ADP-ribosyltransferase produced by Clostridium limosum.</article-title> <source>J. Biol. Chem.</source> <volume>267</volume>: <fpage>10274</fpage>&#x2013;<lpage>10280</lpage>.</citation></ref>
<ref id="bib34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karakaya</surname><given-names>M.</given-names></name><name><surname>Heller</surname><given-names>R.</given-names></name><name><surname>Kunde</surname><given-names>V.</given-names></name><name><surname>Zimmer</surname><given-names>K.-P.</given-names></name><name><surname>Chao</surname><given-names>C.-M.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>Novel mutations in the nonselective sodium leak channel (NALCN) lead to distal arthrogryposis with increased muscle tone.</article-title> <source>Neuropediatrics</source> <volume>47</volume>: <fpage>273</fpage>&#x2013;<lpage>277</lpage>.</citation></ref>
<ref id="bib35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kasap</surname><given-names>M.</given-names></name><name><surname>Bonnett</surname><given-names>K.</given-names></name><name><surname>Aamodt</surname><given-names>E. J.</given-names></name><name><surname>Dwyer</surname><given-names>D. S.</given-names></name></person-group>, <year>2017</year>&#x2003;<article-title>Akinesia and freezing caused by Na(+) leak-current channel (NALCN) deficiency corrected by pharmacological inhibition of K(+) channels and gap junctions.</article-title> <source>J. Comp. Neurol.</source> <volume>525</volume>: <fpage>1109</fpage>&#x2013;<lpage>1121</lpage>.</citation></ref>
<ref id="bib36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x00F6;ro&#x011F;lu</surname><given-names>&#x00C7;.</given-names></name><name><surname>Seven</surname><given-names>M.</given-names></name><name><surname>Tolun</surname><given-names>A.</given-names></name></person-group>, <year>2013</year>&#x2003;<article-title>Recessive truncating NALCN mutation in infantile neuroaxonal dystrophy with facial dysmorphism.</article-title> <source>J. Med. Genet.</source> <volume>50</volume>: <fpage>515</fpage>&#x2013;<lpage>520</lpage>.</citation></ref>
<ref id="bib37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krause</surname><given-names>M.</given-names></name><name><surname>Offermanns</surname><given-names>S.</given-names></name><name><surname>Stocker</surname><given-names>M.</given-names></name><name><surname>Pedarzani</surname><given-names>P.</given-names></name></person-group>, <year>2002</year>&#x2003;<article-title>Functional specificity of G alpha q and G alpha 11 in the cholinergic and glutamatergic modulation of potassium currents and excitability in hippocampal neurons.</article-title> <source>J. Neurosci.</source> <volume>22</volume>: <fpage>666</fpage>&#x2013;<lpage>673</lpage>.</citation></ref>
<ref id="bib38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lackner</surname><given-names>M. R.</given-names></name><name><surname>Nurrish</surname><given-names>S. J.</given-names></name><name><surname>Kaplan</surname><given-names>J. M.</given-names></name></person-group>, <year>1999</year>&#x2003;<article-title>Facilitation of synaptic transmission by EGL-30 Gqalpha and EGL-8 PLCbeta: DAG binding to UNC-13 is required to stimulate acetylcholine release.</article-title> <source>Neuron</source> <volume>24</volume>: <fpage>335</fpage>&#x2013;<lpage>346</lpage>.</citation></ref>
<ref id="bib39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lear</surname><given-names>B. C.</given-names></name><name><surname>Lin</surname><given-names>J.-M.</given-names></name><name><surname>Keath</surname><given-names>J. R.</given-names></name><name><surname>McGill</surname><given-names>J. J.</given-names></name><name><surname>Raman</surname><given-names>I. M.</given-names></name><etal/></person-group>, <year>2005</year>&#x2003;<article-title>The ion channel narrow abdomen is critical for neural output of the Drosophila circadian pacemaker.</article-title> <source>Neuron</source> <volume>48</volume>: <fpage>965</fpage>&#x2013;<lpage>976</lpage>.</citation></ref>
<ref id="bib40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lear</surname><given-names>B. C.</given-names></name><name><surname>Darrah</surname><given-names>E. J.</given-names></name><name><surname>Aldrich</surname><given-names>B. T.</given-names></name><name><surname>Gebre</surname><given-names>S.</given-names></name><name><surname>Scott</surname><given-names>R. L.</given-names></name><etal/></person-group>, <year>2013</year>&#x2003;<article-title>UNC79 and UNC80, putative auxiliary subunits of the NARROW ABDOMEN ion channel, are indispensable for robust circadian locomotor rhythms in Drosophila.</article-title> <source>PLoS One</source> <volume>8</volume>: <fpage>e78147</fpage>.</citation></ref>
<ref id="bib41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Cribbs</surname><given-names>L. L.</given-names></name><name><surname>Perez-Reyes</surname><given-names>E.</given-names></name></person-group>, <year>1999</year>&#x2003;<article-title>Cloning of a novel four repeat protein related to voltage-gated sodium and calcium channels.</article-title> <source>FEBS Lett.</source> <volume>445</volume>: <fpage>231</fpage>&#x2013;<lpage>236</lpage>.</citation></ref>
<ref id="bib42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liebeskind</surname><given-names>B. J.</given-names></name><name><surname>Hillis</surname><given-names>D. M.</given-names></name><name><surname>Zakon</surname><given-names>H. H.</given-names></name></person-group>, <year>2012</year>&#x2003;<article-title>Phylogeny unites animal sodium leak channels with fungal calcium channels in an ancient, voltage-insensitive clade.</article-title> <source>Mol. Biol. Evol.</source> <volume>29</volume>: <fpage>3613</fpage>&#x2013;<lpage>3616</lpage>.</citation></ref>
<ref id="bib43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Littleton</surname><given-names>J. T.</given-names></name><name><surname>Ganetzky</surname><given-names>B.</given-names></name></person-group>, <year>2000</year>&#x2003;<article-title>Ion channels and synaptic organization: analysis of the Drosophila genome.</article-title> <source>Neuron</source> <volume>26</volume>: <fpage>35</fpage>&#x2013;<lpage>43</lpage>.</citation></ref>
<ref id="bib44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lozic</surname><given-names>B.</given-names></name><name><surname>Johansson</surname><given-names>S.</given-names></name><name><surname>Lovric Kojundzic</surname><given-names>S.</given-names></name><name><surname>Markic</surname><given-names>J.</given-names></name><name><surname>Knappskog</surname><given-names>P. M.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>Novel NALCN variant: altered respiratory and circadian rhythm, anesthetic sensitivity.</article-title> <source>Ann. Clin. Transl. Neurol.</source> <volume>3</volume>: <fpage>876</fpage>&#x2013;<lpage>883</lpage>.</citation></ref>
<ref id="bib45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>B.</given-names></name><name><surname>Su</surname><given-names>Y.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name><etal/></person-group>, <year>2007</year>&#x2003;<article-title>The neuronal channel NALCN contributes resting sodium permeability and is required for normal respiratory rhythm.</article-title> <source>Cell</source> <volume>129</volume>: <fpage>371</fpage>&#x2013;<lpage>383</lpage>.</citation></ref>
<ref id="bib46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>B.</given-names></name><name><surname>Su</surname><given-names>Y.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group>, <year>2009</year>&#x2003;<article-title>Peptide neurotransmitters activate a cation channel complex of NALCN and UNC-80.</article-title> <source>Nature</source> <volume>457</volume>: <fpage>741</fpage>&#x2013;<lpage>744</lpage>.</citation></ref>
<ref id="bib47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Nakayama</surname><given-names>M.</given-names></name><etal/></person-group>, <year>2010</year>&#x2003;<article-title>Extracellular calcium controls background current and neuronal excitability via an UNC79&#x2013;UNC80-NALCN cation channel complex.</article-title> <source>Neuron</source> <volume>68</volume>: <fpage>488</fpage>&#x2013;<lpage>499</lpage>.</citation></ref>
<ref id="bib48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>T. Z.</given-names></name><name><surname>Feng</surname><given-names>Z.-P.</given-names></name></person-group>, <year>2011</year>&#x2003;<article-title>A sodium leak current regulates pacemaker activity of adult central pattern generator neurons in Lymnaea stagnalis.</article-title> <source>PLoS One</source> <volume>6</volume>: <fpage>e18745</fpage>.</citation></ref>
<ref id="bib49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lutas</surname><given-names>A.</given-names></name><name><surname>Lahmann</surname><given-names>C.</given-names></name><name><surname>Soumillon</surname><given-names>M.</given-names></name><name><surname>Yellen</surname><given-names>G.</given-names></name></person-group>, <year>2016</year>&#x2003;<article-title>The leak channel NALCN controls tonic firing and glycolytic sensitivity of substantia nigra pars reticulata neurons.</article-title> <source>Elife</source> <volume>5</volume>: <fpage>e15271</fpage>.</citation></ref>
<ref id="bib50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lutz</surname><given-names>S.</given-names></name><name><surname>Freichel-Blomquist</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>R&#x00FC;menapp</surname><given-names>U.</given-names></name><name><surname>Jakobs</surname><given-names>K. H.</given-names></name><etal/></person-group>, <year>2005</year>&#x2003;<article-title>The guanine nucleotide exchange factor p63RhoGEF, a specific link between Gq/11-coupled receptor signaling and RhoA.</article-title> <source>J. Biol. Chem.</source> <volume>280</volume>: <fpage>11134</fpage>&#x2013;<lpage>11139</lpage>.</citation></ref>
<ref id="bib51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lutz</surname><given-names>S.</given-names></name><name><surname>Shankaranarayanan</surname><given-names>A.</given-names></name><name><surname>Coco</surname><given-names>C.</given-names></name><name><surname>Ridilla</surname><given-names>M.</given-names></name><name><surname>Nance</surname><given-names>M. R.</given-names></name><etal/></person-group>, <year>2007</year>&#x2003;<article-title>Structure of Galphaq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs.</article-title> <source>Science</source> <volume>318</volume>: <fpage>1923</fpage>&#x2013;<lpage>1927</lpage>.</citation></ref>
<ref id="bib52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuki</surname><given-names>M.</given-names></name><name><surname>Kunitomo</surname><given-names>H.</given-names></name><name><surname>Iino</surname><given-names>Y.</given-names></name></person-group>, <year>2006</year>&#x2003;<article-title>Goalpha regulates olfactory adaptation by antagonizing Gqalpha-DAG signaling in Caenorhabditis elegans.</article-title> <source>Proc. Natl. Acad. Sci. USA</source> <volume>103</volume>: <fpage>1112</fpage>&#x2013;<lpage>1117</lpage>.</citation></ref>
<ref id="bib53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McMullan</surname><given-names>R.</given-names></name><name><surname>Hiley</surname><given-names>E.</given-names></name><name><surname>Morrison</surname><given-names>P.</given-names></name><name><surname>Nurrish</surname><given-names>S. J.</given-names></name></person-group>, <year>2006</year>&#x2003;<article-title>Rho is a presynaptic activator of neurotransmitter release at pre-existing synapses in C. elegans.</article-title> <source>Genes Dev.</source> <volume>20</volume>: <fpage>65</fpage>&#x2013;<lpage>76</lpage>.</citation></ref>
<ref id="bib54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mello</surname><given-names>C. C.</given-names></name><name><surname>Kramer</surname><given-names>J. M.</given-names></name><name><surname>Stinchcomb</surname><given-names>D.</given-names></name><name><surname>Ambros</surname><given-names>V.</given-names></name></person-group>, <year>1991</year>&#x2003;<article-title>Efficient gene transfer in C. elegans: extrachromosomal maintenance and integration of transforming sequences.</article-title> <source>EMBO J.</source> <volume>10</volume>: <fpage>3959</fpage>&#x2013;<lpage>3970</lpage>.</citation></ref>
<ref id="bib55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mendel</surname><given-names>J. E.</given-names></name><name><surname>Korswagen</surname><given-names>H. C.</given-names></name><name><surname>Liu</surname><given-names>K. S.</given-names></name><name><surname>Hajdu-Cronin</surname><given-names>Y. M.</given-names></name><name><surname>Simon</surname><given-names>M. I.</given-names></name><etal/></person-group>, <year>1995</year>&#x2003;<article-title>Participation of the protein Go in multiple aspects of behavior in C. elegans.</article-title> <source>Science</source> <volume>267</volume>: <fpage>1652</fpage>&#x2013;<lpage>1655</lpage>.</citation></ref>
<ref id="bib56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>K. G.</given-names></name><name><surname>Emerson</surname><given-names>M. D.</given-names></name><name><surname>Rand</surname><given-names>J. B.</given-names></name></person-group>, <year>1999</year>&#x2003;<article-title>Goalpha and diacylglycerol kinase negatively regulate the Gqalpha pathway in C. elegans.</article-title> <source>Neuron</source> <volume>24</volume>: <fpage>323</fpage>&#x2013;<lpage>333</lpage>.</citation></ref>
<ref id="bib57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>P. G.</given-names></name><name><surname>Sedensky</surname><given-names>M. M.</given-names></name></person-group>, <year>1995</year>&#x2003;<article-title>Mutations affecting sensitivity to ethanol in the nematode, Caenorhabditis elegans.</article-title> <source>Alcohol. Clin. Exp. Res.</source> <volume>19</volume>: <fpage>1423</fpage>&#x2013;<lpage>1429</lpage>.</citation></ref>
<ref id="bib58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>E. C.</given-names></name><name><surname>Horvitz</surname><given-names>H. R.</given-names></name></person-group>, <year>1986</year>&#x2003;<article-title>Mutations with dominant effects on the behavior and morphology of the nematode Caenorhabditis elegans.</article-title> <source>Genetics</source> <volume>113</volume>: <fpage>821</fpage>&#x2013;<lpage>852</lpage>.</citation></ref>
<ref id="bib59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>L.</given-names></name><name><surname>Kratsios</surname><given-names>P.</given-names></name><name><surname>Serrano-Saiz</surname><given-names>E.</given-names></name><name><surname>Sheftel</surname><given-names>H.</given-names></name><name><surname>Mayo</surname><given-names>A. E.</given-names></name><etal/></person-group>, <year>2015</year>&#x2003;<article-title>A cellular and regulatory map of the cholinergic nervous system of C. elegans.</article-title> <source>Elife</source> <volume>4</volume>: <fpage>e12432</fpage>.</citation></ref>
<ref id="bib60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>Y.</given-names></name><name><surname>Kadir</surname><given-names>R.</given-names></name><name><surname>Volodarsky</surname><given-names>M.</given-names></name><name><surname>Noyman</surname><given-names>I.</given-names></name><name><surname>Flusser</surname><given-names>H.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>UNC80 mutation causes a syndrome of hypotonia, severe intellectual disability, dyskinesia and dysmorphism, similar to that caused by mutations in its interacting cation channel NALCN.</article-title> <source>J. Med. Genet.</source> <volume>53</volume>: <fpage>397</fpage>&#x2013;<lpage>402</lpage>.</citation></ref>
<ref id="bib61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pierce-Shimomura</surname><given-names>J. T.</given-names></name><name><surname>Chen</surname><given-names>B. L.</given-names></name><name><surname>Mun</surname><given-names>J. J.</given-names></name><name><surname>Ho</surname><given-names>R.</given-names></name><name><surname>Sarkis</surname><given-names>R.</given-names></name><etal/></person-group>, <year>2008</year>&#x2003;<article-title>Genetic analysis of crawling and swimming locomotory patterns in C. elegans.</article-title> <source>Proc. Natl. Acad. Sci. USA</source> <volume>105</volume>: <fpage>20982</fpage>&#x2013;<lpage>20987</lpage>.</citation></ref>
<ref id="bib62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x00E1;nchez-Fern&#x00E1;ndez</surname><given-names>G.</given-names></name><name><surname>Cabezudo</surname><given-names>S.</given-names></name><name><surname>Garc&#x00ED;a-Hoz</surname><given-names>C.</given-names></name><name><surname>Beninc&#x00E1;</surname><given-names>C.</given-names></name><name><surname>Aragay</surname><given-names>A. M.</given-names></name><etal/></person-group>, <year>2014</year>&#x2003;<article-title>G&#x03B1;q signalling: the new and the old.</article-title> <source>Cell. Signal.</source> <volume>26</volume>: <fpage>833</fpage>&#x2013;<lpage>848</lpage>.</citation></ref>
<ref id="bib63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sedensky</surname><given-names>M. M.</given-names></name><name><surname>Meneely</surname><given-names>P. M.</given-names></name></person-group>, <year>1987</year>&#x2003;<article-title>Genetic analysis of halothane sensitivity in Caenorhabditis elegans.</article-title> <source>Science</source> <volume>236</volume>: <fpage>952</fpage>&#x2013;<lpage>954</lpage>.</citation></ref>
<ref id="bib64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x00E9;galat</surname><given-names>L.</given-names></name><name><surname>Elkes</surname><given-names>D. A.</given-names></name><name><surname>Kaplan</surname><given-names>J. M.</given-names></name></person-group>, <year>1995</year>&#x2003;<article-title>Modulation of serotonin-controlled behaviors by Go in Caenorhabditis elegans.</article-title> <source>Science</source> <volume>267</volume>: <fpage>1648</fpage>&#x2013;<lpage>1651</lpage>.</citation></ref>
<ref id="bib65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Senatore</surname><given-names>A.</given-names></name><name><surname>Spafford</surname><given-names>J. D.</given-names></name></person-group>, <year>2013</year>&#x2003;<article-title>A uniquely adaptable pore is consistent with NALCN being an ion sensor.</article-title> <source>Channels</source> <volume>7</volume>: <fpage>60</fpage>&#x2013;<lpage>68</lpage>.</citation></ref>
<ref id="bib66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Senatore</surname><given-names>A.</given-names></name><name><surname>Monteil</surname><given-names>A.</given-names></name><name><surname>van Minnen</surname><given-names>J.</given-names></name><name><surname>Smit</surname><given-names>A. B.</given-names></name><name><surname>Spafford</surname><given-names>J. D.</given-names></name></person-group>, <year>2013</year>&#x2003;<article-title>NALCN ion channels have alternative selectivity filters resembling calcium channels or sodium channels.</article-title> <source>PLoS One</source> <volume>8</volume>: <fpage>e55088</fpage>.</citation></ref>
<ref id="bib67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shamseldin</surname><given-names>H. E.</given-names></name><name><surname>Faqeih</surname><given-names>E.</given-names></name><name><surname>Alasmari</surname><given-names>A.</given-names></name><name><surname>Zaki</surname><given-names>M. S.</given-names></name><name><surname>Gleeson</surname><given-names>J. G.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>Mutations in UNC80, encoding part of the UNC79&#x2013;UNC80-NALCN channel complex, cause autosomal-recessive severe infantile encephalopathy.</article-title> <source>Am. J. Hum. Genet.</source> <volume>98</volume>: <fpage>210</fpage>&#x2013;<lpage>215</lpage>.</citation></ref>
<ref id="bib68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>A. G.</given-names></name><name><surname>Orita</surname><given-names>S.</given-names></name><name><surname>Malone</surname><given-names>C. J.</given-names></name><name><surname>Han</surname><given-names>M.</given-names></name></person-group>, <year>2001</year>&#x2003;<article-title>A RHO GTPase-mediated pathway is required during P cell migration in Caenorhabditis elegans.</article-title> <source>Proc. Natl. Acad. Sci. USA</source> <volume>98</volume>: <fpage>13132</fpage>&#x2013;<lpage>13137</lpage>.</citation></ref>
<ref id="bib69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stray-Pedersen</surname><given-names>A.</given-names></name><name><surname>Cobben</surname><given-names>J.-M.</given-names></name><name><surname>Prescott</surname><given-names>T. E.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Cang</surname><given-names>C.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>Biallelic mutations in UNC80 cause persistent hypotonia, encephalopathy, growth retardation, and severe intellectual disability.</article-title> <source>Am. J. Hum. Genet.</source> <volume>98</volume>: <fpage>202</fpage>&#x2013;<lpage>209</lpage>.</citation></ref>
<ref id="bib70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swayne</surname><given-names>L. A.</given-names></name><name><surname>Mezghrani</surname><given-names>A.</given-names></name><name><surname>Varrault</surname><given-names>A.</given-names></name><name><surname>Chemin</surname><given-names>J.</given-names></name><name><surname>Bertrand</surname><given-names>G.</given-names></name><etal/></person-group>, <year>2009</year>&#x2003;<article-title>The NALCN ion channel is activated by M3 muscarinic receptors in a pancreatic beta-cell line.</article-title> <source>EMBO Rep.</source> <volume>10</volume>: <fpage>873</fpage>&#x2013;<lpage>880</lpage>.</citation></ref>
<ref id="bib71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Topalidou</surname><given-names>I.</given-names></name><name><surname>Cattin-Ortol&#x00E1;</surname><given-names>J.</given-names></name><name><surname>Pappas</surname><given-names>A. L.</given-names></name><name><surname>Cooper</surname><given-names>K.</given-names></name><name><surname>Merrihew</surname><given-names>G. E.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>The EARP complex and its interactor EIPR-1 are required for cargo sorting to dense-core vesicles.</article-title> <source>PLoS Genet.</source> <volume>12</volume>: <fpage>e1006074</fpage>.</citation></ref>
<ref id="bib72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valkanas</surname><given-names>E.</given-names></name><name><surname>Schaffer</surname><given-names>K.</given-names></name><name><surname>Dunham</surname><given-names>C.</given-names></name><name><surname>Maduro</surname><given-names>V.</given-names></name><name><surname>du Souich</surname><given-names>C.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>Phenotypic evolution of UNC80 loss of function.</article-title> <source>Am. J. Med. Genet. A.</source> <volume>170</volume>: <fpage>3106</fpage>&#x2013;<lpage>3114</lpage>.</citation></ref>
<ref id="bib73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vivero</surname><given-names>M.</given-names></name><name><surname>Cho</surname><given-names>M. T.</given-names></name><name><surname>Begtrup</surname><given-names>A.</given-names></name><name><surname>Wentzensen</surname><given-names>I. M.</given-names></name><name><surname>Walsh</surname><given-names>L.</given-names></name><etal/></person-group>, <year>2017</year>&#x2003;<article-title>Additional de novo missense genetic variants in NALCN associated with CLIFAHDD syndrome.</article-title> <source>Clin. Genet.</source> DOI: .<pub-id pub-id-type="doi">10.1111/cge.12899</pub-id></citation></ref>
<ref id="bib74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>S.</given-names></name><name><surname>Grosse</surname><given-names>R.</given-names></name><name><surname>Schultz</surname><given-names>G.</given-names></name><name><surname>Offermanns</surname><given-names>S.</given-names></name></person-group>, <year>2003</year>&#x2003;<article-title>Receptor-dependent RhoA activation in G12/G13-deficient cells: genetic evidence for an involvement of Gq/G11.</article-title> <source>J. Biol. Chem.</source> <volume>278</volume>: <fpage>28743</fpage>&#x2013;<lpage>28749</lpage>.</citation></ref>
<ref id="bib75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Koh</surname><given-names>K.</given-names></name><name><surname>Ichinose</surname><given-names>Y.</given-names></name><name><surname>Yasumura</surname><given-names>M.</given-names></name><name><surname>Ohtsuka</surname><given-names>T.</given-names></name><etal/></person-group>, <year>2016</year>&#x2003;<article-title>A de novo mutation in the NALCN gene in an adult patient with cerebellar ataxia associated with intellectual disability and arthrogryposis.</article-title> <source>Clin. Genet.</source> <volume>90</volume>: <fpage>556</fpage>&#x2013;<lpage>557</lpage>.</citation></ref>
<ref id="bib76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weernink</surname><given-names>P. A. O.</given-names></name><name><surname>Meletiadis</surname><given-names>K.</given-names></name><name><surname>Hommeltenberg</surname><given-names>S.</given-names></name><name><surname>Hinz</surname><given-names>M.</given-names></name><name><surname>Ishihara</surname><given-names>H.</given-names></name><etal/></person-group>, <year>2004</year>&#x2003;<article-title>Activation of type I phosphatidylinositol 4-phosphate 5-kinase isoforms by the Rho GTPases, RhoA, Rac1, and Cdc42.</article-title> <source>J. Biol. Chem.</source> <volume>279</volume>: <fpage>7840</fpage>&#x2013;<lpage>7849</lpage>.</citation></ref>
<ref id="bib77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilkie</surname><given-names>T. M.</given-names></name><name><surname>Scherle</surname><given-names>P. A.</given-names></name><name><surname>Strathmann</surname><given-names>M. P.</given-names></name><name><surname>Slepak</surname><given-names>V. Z.</given-names></name><name><surname>Simon</surname><given-names>M. I.</given-names></name></person-group>, <year>1991</year>&#x2003;<article-title>Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines.</article-title> <source>Proc. Natl. Acad. Sci. USA</source> <volume>88</volume>: <fpage>10049</fpage>&#x2013;<lpage>10053</lpage>.</citation></ref>
<ref id="bib78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilkie</surname><given-names>T. M.</given-names></name><name><surname>Gilbert</surname><given-names>D. J.</given-names></name><name><surname>Olsen</surname><given-names>A. S.</given-names></name><name><surname>Chen</surname><given-names>X. N.</given-names></name><name><surname>Amatruda</surname><given-names>T. T.</given-names></name><etal/></person-group>, <year>1992</year>&#x2003;<article-title>Evolution of the mammalian G protein alpha subunit multigene family.</article-title> <source>Nat. Genet.</source> <volume>1</volume>: <fpage>85</fpage>&#x2013;<lpage>91</lpage>.</citation></ref>
<ref id="bib79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>S. L.</given-names></name><name><surname>Lutz</surname><given-names>S.</given-names></name><name><surname>Charlie</surname><given-names>N. K.</given-names></name><name><surname>Vettel</surname><given-names>C.</given-names></name><name><surname>Ailion</surname><given-names>M.</given-names></name><etal/></person-group>, <year>2007</year>&#x2003;<article-title>Trio&#x2019;s Rho-specific GEF domain is the missing Galpha q effector in C. elegans.</article-title> <source>Genes Dev.</source> <volume>21</volume>: <fpage>2731</fpage>&#x2013;<lpage>2746</lpage>.</citation></ref>
<ref id="bib80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Alcaire</surname><given-names>S. M.</given-names></name><name><surname>Aoyagi</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group>, <year>2013</year>&#x2003;<article-title>NLF-1 delivers a sodium leak channel to regulate neuronal excitability and modulate rhythmic locomotion.</article-title> <source>Neuron</source> <volume>77</volume>: <fpage>1069</fpage>&#x2013;<lpage>1082</lpage>.</citation></ref>
<ref id="bib81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>E.</given-names></name><name><surname>Ng</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Bouhours</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group>, <year>2008</year>&#x2003;<article-title>A putative cation channel, NCA-1, and a novel protein, UNC-80, transmit neuronal activity in C. elegans.</article-title> <source>PLoS Biol.</source> <volume>6</volume>: <fpage>e55</fpage>.</citation></ref>
</ref-list></back>
</article>
